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Abstract 
Iron is vital for all living creatures but becomes toxic when it exceeds the levels catered for by 
their natural cellular buffering mechanisms, causing free radical formation via the Fenton 
reaction and ultimately, therefore, leading to oxidative stress. In such situations, for example in 
repeatedly transfused patients suffering from β-thalassaemia or sickle cell anaemia, iron 
chelation therapy is required. Desferioxamine (DFO), the most widely used therapeutic chelator, 
is a hexadentate ligand possessing a very high affinity for Fe3+, but it is not orally active. 3-
hydroxypyridin-4-ones (HPOs), the more recently introduced synthetic alternatives, have also 
been shown to be useful therapeutic chelators, demonstrating the essential affinity and 
selectivity for Fe3+ along with good oral activity. Deferiprone, a typical HPO, has emerged as a 
prominent therapeutic, able to remove accumulated excess iron from the heart and 
mitochondria. However, because Deferiprone has some drawbacks of relatively high metabolic 
instability and a side effect of lowering white blood cell count for a small number of patients, the 
search continues for other such synthetic chelators with improved properties. In the work 
reported here, various computational studies have been performed to aid in the rational design 
of Fe3+ chelators, with their physicochemical properties (pKa, Fe3+ affinity, hydration and 
membrane permeability) predicted by means of quantitative structure property relationship 
(QSPR) methods, quantum mechanical (QM) calculations, and molecular dynamic (MD) 
simulations. The pKa and Fe3+ affinity were also studied experimentally with a novel approach 
devised for dealing with ligands possessing substituents with hydrogen bond donor and/or 
acceptor groups. The pKa values predicted using QSPR and QM static calculations (Gaussian 
09) were found to differ very significantly from the experimentally determined values. When data 
from the QM static calculations were combined with a regression model, however, the pKa 
predictions were significantly improved, with the predicted values then within ± 0.2 log units of 
the experimental values, and computing times of the order of 1 day per molecule. These 
calculations also allowed the determination of possible deprotonation sequences for the 
predicted compounds. Further pKa predictions were made by means of QM MD calculations, 
using Car-Parrinello molecular dynamics (CP-MD). These simulations were found to yield pKa 
values within ± 0.3 log units of the experimental values but involved much longer computing 
times (of the order of 20 days per molecule). In addition, however, the CP-MD simulations also 
provided valuable insights into the atomistic details of the proton transfer mechanism and the 
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solvation structure and dynamics at all stages of the reaction. For the three HPOs studied, it 
was observed that proton transfer takes place along a chain of three H2O molecules, although 
direct hydrogen bonds were observed to form transiently. The (Fe3+) log K1 predictions for the 
HPOs were made using an entirely novel QM-based methodology (and without knowledge of 
the chelator pKa values), yielding log K1 values within ± 0.32 log units of the experimental values. 
For the preparation of membrane permeability study, novel Chemistry at HARvard Molecular 
Mechanics (CHARMM) force fields specifically for use in HPO simulations were developed. 
These new force fields were validated using Large-scale Atomic/Molecular Massively Parallel 
Simulator (LAMMPS) MD simulations of the chelators’ behaviour in aqueous solution. 
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Chapter 1 Introduction 
Iron is one of the most abundant elements on Earth and is essential for all living creatures. Due 
to the nature of its incompletely-filled d-orbitals, a variety of iron valence forms can exist, the 
most stable of which in aqueous solution are Fe2+ and Fe3+. The redox potential between these 
two forms can be associated with a diversity of metabolic reactions. Although iron is vital for all 
living cells, it becomes toxic when accumulated in excess. The labile iron can redox cycle 
between Fe2+ and Fe3+ via the Fenton reaction to generate hydroxyl radicals in the presence of 
molecular oxygen (Crisponi and Remelli, 2008), thereby giving rise to oxidative stress, which 
can lead to cell damage (Figure 1-1). In normal individuals, iron levels are controlled tightly and 
this creates little opportunity to initiate iron-catalysed free radical generation. However, the iron 
status can vary either systemically as with transfusion-induced iron overload or genetic 
haemochromatosis, or locally as in ischaemic tissue. In such situations, the elevated iron levels 
can result in free radical-mediated tissue/organ damage and death (Hoffman, 1991). Thus, iron 
chelators are required to remove such excess iron. The most widely-used therapeutic iron 
chelator in haematology over the past 40 years has been Desferrioxamine-B (DFO; Figure 1-2), 
a hexadentate ligand, which suffers the major drawback of being orally inactive (Hershko et al., 
1998). There are numerous different synthetic organic compounds that are able to chelate iron 
(see Figure 1-3). Ideal iron chelators for clinical use are still searched for and careful design is 
required to balance their physicochemical properties, such as metal affinity, selectivity and iron-
complex stability with their biological attributes of bioavailability and toxicity. 
 
Figure 1-1 Labile iron pool-induced oxidative stress and the many biological functions it may cause to fail 
(Weinreb et al., 2010). 
 












































































































Figure 1-3 Structures of selective chelating agents. 
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1.1 Iron chelation therapy 
1.1.1 Clinical applications 
1.1.1.1 Systemic iron overload 
Blood transfusion is the most prevalent treatment for inherited haematological diseases such as 
β-thalassaemia major. Regular blood transfusion can give rise to elevated body iron levels 
because no physiological excretion routes exist in humans. Each unit of blood (0.40 L) contains 
approximately 0.25 g of iron and thus, the patient starts to accumulate excess iron when 
receiving more than two units per year. In the treatment of thalassaemia major, transfusions are 
normally carried out monthly and thus, more than 2.5 g of iron per patient per year is 
accumulated in the absence of iron chelation therapy (a normal adult human has a total of 4-5 g 
of body iron). Excess iron largely accumulates within the liver and the spleen, and if patients are 
not further treated, death generally takes place in the second decade of life arising from 
infection or heart disease (Hoffman, 1991). Because iron chelation therapy counteracts the 
excessive accumulation of iron, thalassaemia major patients can have significantly higher life 
quality than before. For young patients, bone marrow transplantation can be considered as an 
alternative treatment with disadvantages of expense and limited availability. As a result, the use 
of effective orally active iron chelators is much preferred (Porter, 1997). 
For the treatment of sickle cell anaemia, transfusion has been introduced more recently 
because there are advantageous effects to treat crises and to diminish the incidence of stroke 
(Reed and Vichinsky, 1998). An effective orally active iron chelator, again, allows such patients 
to receive regular transfusion without the side effect of being iron overloaded. There are a huge 
number of humans carrying thalassaemia and sickle cell genes in tropical and subtropical 
regions of the world due to the beneficial effect for heterozygous gene carriers against malaria 
infection. 
Excessive absorption of iron from the daily diet can also cause iron overload. For an 
adult human, 1 mg of iron per day is normally absorbed under tight control. Several inherited 
diseases are related to enhanced iron absorption, for instance genetic haemochromatosis which 
is prevalent in Northern Europe and North America. Iron overload can lead to many pathological 
symptoms, for example heart failure, liver cirrhosis and diabetes, which commonly appear in the 
fourth or fifth decade of such patients, when their total body iron level reaches 20-40 g (Barton 
and Edwards, 2000). Secondary increased iron absorption may also be associated with some 
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focus of anaemia, particularly in thalassaemia intermedia patients. For such patients, regular 
blood transfusions may not be necessary to influence their haemoglobin level. Nevertheless, 
because of increased iron absorption from the gastrointestinal tract, the iron overload-inducing 
symptoms occur typically in the fourth or fifth decade of their lives (Pippard et al., 1979). Thus, 
iron chelation therapy can be beneficial for these patients.  
Effective iron chelators should possess  a pFe3+ value (to be discussed in detail in Metal 
selectivity and affinity section) of approximately 20 (Zhou et al., 2012). If the pFe3+ value of an 
iron chelator is much lower than 20, the chelator is unable to scavenge Fe3+ efficiently under 
physiological conditions. On the contrary, if the pFe3+ value is much higher than 20, the chelator 
is able to compete with iron-binding proteins, such as transferrin, which results in toxic effects.  
1.1.1.2 Neurodegeneration (localised iron overload) 
In principle, chelation therapy could be useful for the treatment of neurodegenerative diseases 
related to elevated redox active metal ions in the brain and eye, such as Parkinson’s disease 
(PD), Alzheimer’s disease (AD), Friedreich’s ataxia, macular degeneration and Hallervorden-
Spatz syndrome (Hider et al., 2011). Neurodegeneration is conventionally defined as a 
progressive loss of function or structure of neurons, including neuron death, in an age-related 
way. Promising pharmacological targets for the treatment are oxidative stress and protein 
aggregation (Gaeta and Hider, 2005; Sigel et al., 2006). Oxidative stress is defined as an 
imbalance between the generation of free radicals and the capability of detoxifying enzymes 
and antioxidants in the body to reverse them. Oxidative damage occurring in the brain is 
significant because the brain consumes a high amount of oxygen and contains a relatively low 
quantity of antioxidants. Furthermore, the brain accumulates redox active metals with age 
(Crichton and Ward, 2006). Redox active metal ions can be bound to misfolded or partially 
degraded proteins and thus produce free radicals through redox cycling. This reaction is found 
to be a critical hallmark in many neurodegenerative diseases (Crichton and Ward, 2006). In 
order to remove free redox active metal ions in the brain, an adequate chelator must be capable 
of crossing the blood-brain barrier (BBB) and sequestering the elevated levels of metal to form 
non-toxic metal complexes, which can be excreted. Again, an effective iron chelator for this 
purpose should possess a pFe3+ value of approximately 20. The ability to permeate the BBB is 
another crucial factor for the chelator. A molecular weight less than 400 Da and the presence of 
less than 8 hydrogen bonds are suggested to be ideal properties for this (Pardridge, 2012). In 
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order to meet this requirement, the choice of chelators is limited and most hexadentate ligands 
are excluded. However, an extremely large number of bidentate molecules will comply with 
these limiting guide lines. 
1.1.1.3 Bacteriostatic activity 
All bacteria and fungi require iron for survival. The bioavailability of iron under aerobic 
environments is restricted due to the insolubility of Fe(OH)3 and microorganisms have thus 
evolved the ability to concentrate iron from the environment. One effective means for iron 
absorption is through the use of siderophores, which are compounds of 500-1500 Da molecular 
weight, possessing a high affinity and selectivity for Fe3+ (Hider and Kong, 2010). There are 
three main routes of bacteriostatic or antimicrobial activity provided by iron chelating agents:  
1. to compete effectively with microbial siderophores for iron and not to be recognised by the 
cell receptors, thereby competing for the iron supply;  
2. to use a siderophore analogue which inhibits the siderophore uptake protein, precluding the 
microbial siderophores from being transported across the cell membrane, also restricting the 
iron supply;  
3. the “Trojan Horse” approach is to attach an antimicrobial agent to a siderophore backbone, 
together transported into the cell with its iron-complex. Following the iron release of the complex 
inside the cell, a series of reactions are triggered to activate the antimicrobial activity of the 
cargo (Crumbliss and Harrington, 2009).  
8-hydroxyquinoline (Figure 1-3) and related compounds were the first chelators to be 
reported to possess antimicrobial properties more than 50 years ago (Albert et al., 1947; Lowe 
and Phillips, 1962). N,N’-ethylenebis[2-(2-hydroxyphenyl)-glycine], a hexadentate chelator, has 
also been found to demonstrate appreciable activity against isolates of pathogenic bacteria and 
fungi, while EDTA and DTPA (Figure 1-3) exhibit weaker activity (Bergan et al., 2001). EDTA 
treatment of P. aeruginosa biofilms is reported to cause one thousand times more killing than 
gentamicin treatment (Banin et al., 2006). 
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1.1.2 Design features of iron chelators with clinical potential 
1.1.2.1 Metal selectivity and affinity 
In theory, chelators can be designed with preference for either Fe3+ or Fe2+. Due to the 
difference of charge density between Fe3+ and Fe2+, the preference of ligating atoms is not the 
same – Fe3+ favours highly charged donors, such as oxygen anions, but Fe2+ favours low 
charged donors, such as nitrogen or sulphur. Ligands in favour of Fe2+, such as 2,2’-bipyridyl 
and 1,10-phenanthroline (Figure 1-3), can retain appreciable affinities for other biologically 
important dipositive metal ions, such as Zn2+ and Cu2+ (Table 1-1). Thus, the design of non-toxic 
Fe2+-selective chelators is difficult, while Fe3+-selective chelators, typically containing oxygen 
anions provided by hydroxamates and catecholates, are generally more selective for tripositive 
metal ions rather than dipositive ones. In addition, most tripositive metal ions, for example Al3+ 
and Ga3+, are not essential for life and thus, Fe3+ is regarded as the best target for iron chelator 
design under physiological conditions. High affinity Fe3+ chelators have an additional feature 
that when chelating Fe2+, the Fe2+-complexes can be rapidly autoxidised to the corresponding 
Fe3+-complexes under aerobic conditions at physiological pH (Harris and Aisen, 1973). 
Table 1-1 Metal affinity constants for selected ligandsa 
Log cumulative stability constant Ligand 
Fe3+ Al3+ Ga3+ Cu2+ Zn2+ Fe2+ 
Desferrioxamine-B 30.6 25.0 27.6 14.1 11.1 7.2 
2,2’-Bipyridyl 16.3 – 7.7 16.9 13.2 17.2 
1,10-Phenanthroline 14.1 – 9.2 21.4 17.5 21.0 
N,N-Dimethyl-2,3-dihydroxybenzamide 40.2 – – 24.9 13.5 17.5 
Acetohydroxamic acid 28.3 21.5 – 7.9 9.6 8.5 
Deferiprone 37.2 35.8 32.6 21.7 13.5 12.1 
8-Hydroxyquinoline 36.9 33.4 32.9 23 15.8 15.0 
EDTA 25.1 16.5 21.0 18.8 16.5 14.3 
DTPA 28.0 18.6 25.5 21.6 18.4 16.5 
a experimental values taken from Martell and Smith (1974-1989). Ligand structures can be found in Figures 1-2 and 1-3. 
 Because Fe3+ is a positively charged ion, most effective iron chelators are negatively 
charged species, also attracting H+ and thus, leading to the inevitable competition between Fe3+ 
and H+. The equilibrium expression (Koverall) of the formation Fe3+-ligand(L) complex must take 
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The constant Koverall is a pH-dependent conditional equilibrium constant. However, the stability 
constants found in the literature, for example, the values in Tables 1-1 and 1-2, and the 











The constant K may be convenient to compare various chelators with different protonation 
constants (assuming ligands deprotonate completely) in a theoretical sense but this does not 
account for the important competition between Fe3+ and H+ in aqueous solution, particularly at 
physiological pH. In order to compare different chelators in a meaningful way, pFe3+ is generally 
adopted as –log[Free Fe3+] under the conditions that [Fe3+]total is 10-6 M and [Ligand]total is 10-5 M 
at pH 7.4 (Chaberek and Martell, 1959) (a condition-sensitive indicator, Figure 1-4). This takes 
into account the impact of ligand denticity, protonation and differences in Fe3+-ligand 
stoichiometries. For a bidentate ligand, such as deferiprone, the calculation of pFe3+ requires at 
least the five equations (1-5) (the cumulative constant β can be used alternatively, for example 
β2 = K1 x K2; β3 = K1 x K2 x K3). If the Fe3+ affinity of a ligand is not strong, the hydrolysis 
equilibrium constants of iron need to be included. The lowest pFe3+ value for chelators with a 
weak Fe3+ affinity is 14.6, reflecting the Fe3+ affinity for OH- (the mixture of [Fe(OH)2]+ and 
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Figure 1-4 pFe3+ as a function of pH when [Fe3+]total is 10-6 M and [Ligand]total is 10-5 M (Valdebenito et al., 
2006). 
Enterobactin (solid line), aerobactin (dashed line), and desferrioxamine-B (dotted line). The structures can be found in 
Figure 1-2. 
























Figure 1-5 Speciation plot for Fe3+ in aqueous solution in the absence of binding chelators. 
 
1.1.2.2 Redox activity 
As mentioned above, iron can assist to generate free radicals from redox cycling through the 
Fenton reaction. 
          (6) 
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A therapeutic iron chelator should have an ability to preclude this reaction under physiological 
conditions and the reduction potential of the iron complex should thus be outside the range of 
common oxidants and reductants in biological systems (Figure 1-6). The iron complexes of high 
Fe3+-selective chelators/siderophores possess low reduction potentials, such as enterobactin: -
750 mv/NHE, desferrioxamine-B: -468 mv/NHE and deferiprone: -620 mv/NHE (Hider and Kong, 
2010; Merkofer et al., 2004). The reduction potentials of iron complexes generally reflect the 
selectivity and affinity of chelators for Fe3+ – the lower the reduction potential, the higher the 
pFe3+ (Figure 1-7). As pFe3+ is sensitive to pH, the reduction potential is also pH dependent – 
the lower the reduction potential, the higher the pH (Crumbliss and Harrington, 2009). 
 
Figure 1-6 Reduction potentials (mV) of important biological reactions and iron-chelator complexes 
(Crisponi and Remelli, 2008). If the reduction potential of an iron-chelator complex is within the gray area, 
the complex is susceptible to redox cycling to generate free radicals. 
 
Figure 1-7 Reduction potentials (E1/2) as a function of pFe3+ values for hexadentate chelators (Crumbliss 
and Harrington, 2009). 
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1.1.2.3 Chelator structure 
With a view to the prevention of free radical generation, the coordination sites of iron should be 
completely occupied by chelators to avoid access by oxygen or hydrogen peroxide. The optimal 
number of coordination atoms for Fe3+ is provided by most hexadentate chelators, such as 
desferrioxamine-B (Figure 1-8) and the iron-complex is relatively more kinetically stable than 
tridentate and bidentate analogues. This leads to efficient iron sequestration which minimises 
hydroxyl radical generation. In addition, a lower ligand concentration is required for hexadentate 
chelators to bind iron. pH-independent equilibrium constants for generic hexadentate, tridentate 
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Expression of these equilibrium constants is rearranged to the ratio of chelated to unbound iron 






















                    (12) 
In order to obtain the same level of iron scavenging, a higher ligand concentration is required for 
bidentate and tridentate chelators (assuming equivalent values for βhexadentate, βtridentate and 
βbidentate) than for hexadentate chelators. Furthermore, hexadentate chelators generally possess 
higher pFe3+ values than tridentate and bidentate analogues and this can be due to the 
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preorganisation of hexadentate structures prior to binding iron, minimising the conformational 
change before and after iron chelation – the lower the conformational freedom of the unbound 
chelator, the higher the iron-complex stability (Zhou et al., 2012). From a kinetic perspective, 
chelators can bind or release iron dynamically due to the competition of water, hydroxide ion or 
other chelating agents in aqueous solution and hexadentate structures constrain the freedom of 
their chelating groups moving away from bound iron to minimise the dynamics (Crumbliss and 
Harrington, 2009). For these reasons, the majority of natural siderophores are hexadentate 
chelators (Hider and Kong, 2010). 
 
Figure 1-8 Space-filling molecule of iron-desferrioxamine-B crystal structure (a fac, left-hand propeller 
isomer) (Dhungana et al., 2001).  
1.1.2.4 Lipophilicity and molecular weight 
With a view to optimising the therapeutic effect for iron chelators, any compound must reach the 
target sites at sufficient concentration. An orally active iron chelator should thus have an ability 
to be absorbed from the gastrointestinal tract efficiently and to cross biological membranes, 
accessing target sites. Three main factors affect drug membrane permeability; these are 
molecular weight, lipophilicity and ionisation state. Following the Lipinski rule of five (Lipinski et 
al., 1997), a compound with good absorption or penetration should possess less than 5 
hydrogen bond donors, less than 10 hydrogen bond acceptors, a molecular weight less than 
500 Da, a calculated logP less than 5. The ionic state of the compound also affects the 
membrane permeability – uncharged species generally permeate biological membranes faster 
than charged ones. In order to comply with these conditions, the choice of iron chelators is 
limited and most hexadentate ligands are excluded due to their molecular weights being more 
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than 500 Da. Bindentate and tridentate ligands are superior candidates for higher absorption 
efficiency because of their much lower molecular weights. 
1.1.2.5 Enzyme inhibition 
Haem-containing enzymes are not generally directly inhibited by iron chelators because their 
porphyrin groups sequester iron tightly. In contrast, non-haem iron-containing enzymes, for 
example the lipoxygenase, aromatic hydroxylase and ribonucleotide reductase, can be inhibited 
by iron chelators (Hider, 1995; Hider et al., 1992). For hydroxypyridinones, more hydrophobic 
derivatives tend to inhibit lipoxygenases (Abeysinghe et al., 1996) – when the size of the 1-alkyl 
substitution at the pyridinone ring is increased in a linear manner but it is less evident for the 
increased size of the 2-substituents (Liu et al., 2002). Indeed, changes in the inhibitory 
properties of hydroxypyridinones related to various 2-substituents depends more on the size of 
the substituent than the lipophilicity of the structure (Figure 1-9). The introduction of a 
hydrophilic 2-substituent for hydroxypyridinones reduces the inhibition significantly, presumably 
due to a steric effect precluding optimal reaction at the enzyme iron-binding site (Liu et al., 
2002). Clearly, iron chelators can be designed to minimise inhibitory effects on a majority of 























Figure 1-9 Relationship between the hydroxypyridinones with different 2-substituents and the inhibition of 
5-lipoxygenase (Liu et al., 2002). 
The biological activity = log [P (1-P)-1], where P is the enzyme percentage inhibition. 
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1.1.2.6 Ligand selection for iron(III) 
Catechols 
Catechol structures possess a high Fe3+ affinity due to the high electron density of the two 
hydroxyl oxygens. This can also be related to the high affinity for H+ (pKa values, 12.1 and 8.4) 
and thus, the cation affinity of catechol is highly pH sensitive (Hider et al., 1981). For bidentate 
catechols, the 2 : 1 Fe3+-complex is the dominant form at physiological pH and thus, oxidants 
and reductants can access the iron resulting in redox cycling. 
Hydroxamates 
Hydroxamate structures possess a lower Fe3+ affinity than catechols but the metal ion selectivity 
is in favour of tripositive over dipositive cations (Table 1-1). The pKa values of hydroxamates (~ 
9) are lower than for catechols and thus H+ competition at pH 7.4 is less pronounced. As a 
result, for bidentate hydroxamates, the 3 : 1 Fe3+-complex is the dominant form at physiological 
pH when the ligand concentration is sufficient. However, the Fe3+ affinity of bidentate 
hydroxamates is insufficient to scavenge iron at pH 7.4 at clinically achievable ligand 
concentrations and so only tetradentate and hexadentate hydroxamates are effective iron 
sequesters under physiological conditions. 
Hydroxypyridinones 
Hydroxypyridinone structures possess balanced features between catechols and hydroxamates 
and also prefer to coordinate tripositive metal ions with two oxygen atoms. Three classes of 
hydroxypyridinones capable of acting as bidentate ligand exist, namely 1-hydroxypyridin-2-one, 
3-hydroxypyridin-2-one and 3-hydroxypyridin-4-one. Their Fe3+ affinities correspond to the pKa 
values of their chelating oxygen atoms – the higher the Fe3+ affinity, the higher the pKa value 
(Table 1-2). 3-Hydroxypyridin-4-ones possess the highest Fe3+ affinity in these three classes 
and are selective for tripositive metal ions (Table 1-1). The carbonyl oxygen possesses 
significantly higher pKa value than the other two classes, resulting from the delocalisation of an 
electron lone pair associated with the aromatic nitrogen (Figure 1-10). This class of compounds 
are neutral at pH 7.4, and their 3 : 1 Fe3+-complexes are also neutral and the dominant form at 
physiological pH. This feature assists both the ligand and the Fe3+-complex to cross biological 
membranes readily. 3-Hydroxypyridin-4-ones possess lower pH-independent log β3 values than 
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catechols but the corresponding pFe3+ values are higher (Table 1-2). This is mainly because the 
3-hydroxypyridin-4-ones possess lower pKa values. 
 





Data sourced from Liu and Hider (2002) but pFe3+ values (–log[Free Fe3+] under the conditions that [Fe3+]total is 10-6 M 
and [Ligand]total is 10-5 M at pH 7.4) were re-calculated. The structures can be found in Figure 1-3. 
 
 
Figure 1-10 Resonance structures of deferiprone (percentages of each species were estimated by Xiao et 
al., 1992). 
 
1.2 Essential computational chemistry 
1.2.1 Structure-property relationships 
Structure-property relationships are qualitatively or quantitatively empirically derived 
relationships between molecular structure and measured properties. In the current literature, 
this normally implies a quantitative mathematical relationship, frequently obtained using curve 
fitting programs to optimise a linear combination of molecular information variables for 
predictions of desired properties. The molecular information variables can be derived from 
molecular descriptors through simple algorithms or complicated molecular modelling 
computations. When the desired property is a physical property, the relationship is referred to 
as a quantitative structure property relationship (QSPR). When the desired property is a 
biological activity, the relationship is referred to as a quantitative structure activity relationship 
(QSAR). Due to the use of an empirical relationship, the computing time for predictions is 
Ligand pKa1 pKa2 Log β3 pFe3+
N,N-Dimethyl-2,3-dihydroxybenzamide (DMB) 8.4 12.1 40.2 14.7 
Acetohydroxamic acid – 9.4 28.3 14.7 
2-Methyl-3-hydroxypyran-4-one (maltol) – 8.7 28.5 15.3 
1-Hydroxypyridin-2-one – 5.8 27.0 17.5 
1-Methyl-3-hydroxypyridin-2-one 0.2 8.6 32.0 18.9 
1,2-Dimethyl-3-hydroxypyridin-4-one (deferiprone) 3.6 9.9 37.2 20.3 
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generally short (typically only requiring a few minutes on a current PC) but the transferability for 
a compound outside the original training set is questionable. 
1.2.2 Force field methods 
In force field (FF) methods, the electronic energy is described as a parametric function of the 
nuclear coordinates and the parameters are fitted to experimental or high level computational 
data. The basic components of FF methods are atoms, and electrons are not explicitly taken 
into account. This leads to the requirement of explicit bonding information and the neglect of 
quantum mechanical nuclear motion. The movement of the atoms is described by classical 
mechanics, Newton’s second law. Molecules are modelled as an ensemble of “balls and 
springs” with different atom sizes, bond lengths and interaction strengths (Jensen, 2007). These 
methods are also referred to as molecular mechanics (MM) methods. The basic idea of these 
methods is the observation that structurally similar molecular units tend to be found in different 
molecules. For example, CH bond lengths are approximately constant in all molecules (between 
1.06 and 1.10 Å). The CH stretch vibrations are also similar (between 2900 and 3300cm−1), 
relating to the CH bond force constants. The concept that molecules consist of structural units 
(functional groups) that behave similarly in different molecules is fundamental in organic 
chemistry. FF methods are in a sense a generalisation of this, with the flexibility of atoms and 
bonds not being fixed to a single dimension. FF computation additionally predicts the relative 
energies or barriers for changes in conformation. The calculations of structurally similar 
molecules are achieved by an appropriate choice of atom types introduced in FF models, which 
depend on the atomic number and the type of chemical bonding to adjacent atoms.  
 The FF calculated energy is generally written as 
EFF = Estretch + Ebend + Etorsion + Evdw + Eelectro + Ecross 
where Estretch represents the stretching energy for a bond between two atoms, Ebend represents 
the bending energy for an angle, Etorsion represents the torsional energy for a bond rotation, Evdw 
represents the van der Waals energy, Eelectro represents the electrostatic energy (Evdw and Eelectro 
account for the non-bonded atom–atom interactions) and Ecross represents the coupling effect 
among the first three terms (some MM programs lacking this term) (Figure 1-11). Following this 
energy function of the nuclear coordinates, optimised relative energies and geometries can be 
achieved. 
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Figure 1-11 Schematic diagram of the “balls and springs” model for force field energy terms (Jensen, 
2007). 
The simplest function used for Estretch is usually a harmonic oscillator equation, derived 
from a Taylor expansion. 
EstretchAB = kAB (RAB – RoAB)2 
where A and B represent two different atoms, R represents the distance between two atoms A 
and B, Ro represents the optimised parameter and k represents the force constant for the AB 
bond (Ro and k are obtained by fitting to experimental or high level computational data). This 
form is sufficient for the determination of most equilibrium geometries and simulations at 300K 
(reasonably accurate up to ~ 8 kcal mol-1) (Jensen, 2007). If higher accuracy is required, the 
most straightforward modification is to add higher order terms of the Taylor expansion, fitting 
more parameters. 
Ebend is the energy for bending an angle and the simplest function is also a harmonic 
expansion, which is sufficient for most applications. 
EbendABC = kABC (θABC  – θoABC)2 
where A, B and C represent three different atoms, θ represents the angle between the two 
bonds AB and BC, θ o represents the optimised parameter and k represents the force constant 
for the ABC angle (θo and k are obtained by fitting to experimental or high level computational 
data). By analogy with Estretch, higher order Taylor expansion terms can be included for more 
accurate computation. 
Etorsion is the energy for rotating a BC bond in a four atoms sequence ABCD, where AB, 
BC and CD are bonded. The torsional angle is defined as the angle formed between the AB and 
CD bonds when the system is viewed along the BC bond. The torsional energy is significantly 
different from Estretch and Ebend: 
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1. The non-bonded terms (Evdw + Eelectro) and the torsional energy can influence rotational 
barrier together and thus, the torsional parameters are closely related to the non-bonded 
parameters. 
2. Periodicity of the torsional energy function must be complied – the energy should return to 
the same value when the bond is rotated 360o.  
3. The rotation expenditure in energy tends to be low and thus, large deviations from the 
minimum energy structure may arise. A Taylor expansion in this case is not adequate. 
Thus, Etorsion is generally written as a Fourier series and the simplest function in an attempt to 
simulate large systems can be expressed as 
Etorsion = kABCD (1 + cos(n ΦABCD – δ)) 
where A, B, C and D represent four different atoms, Φ represents the torsional angle, n 
represents the periodicity of the torsion (for example, n = 1 term means periodicity by 360o, n = 
2 term means periodicity by 180o), δ represents a phase factor and k represents the force 
constant for the ABCD torsional angle (n, δ and k are obtained by fitting to experimental or high 
level computational data). Higher order terms can be included to modify the detailed shape of 
the rotation barrier profile. An out-of-plane motion can be described by an improper torsion 
(Figure 1-12), which is also composed of four atoms and can be controlled by the same function 
(or a harmonic function). 
d 
 
Figure 1-12 Out-of-plane motion described by an improper torsion (red line). 
Evdw is the van der Waals energy which describes the attraction or repulsion among 
non-bonded atoms, as one part of non-bonded energy. This may be explained as the non-polar 
part of the non-bonded interaction, which is not associated with electrostatic energy arising from 
atomic charges. This mainly results from induced dipole-dipole (and/or other multipole-multipole) 
interactions due to a slightly uneven distribution of transient electron movement (electron 
correlation). Evdw is very positive at short distances, becomes slightly negative to a minimum at 
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the interatomic contacting distance, and approaches zero as the distance increases. A widely-
used function for this is the Lennard-Jones (LJ) potential (Jones, 1924). 
ELJ(R) = ε [(Ro R-1)12 – 2(Ro R-1)6] 
where Ro is the minimum energy distance and ε is the depth of the minimum. The choice of the 
exponent in the repulsive part to be twelve is only for a computational convenience without 
theoretical argument. Different programs may have slightly modified forms derived from the 
above function. 
Eelectro is the other part of non-bonded energy due to internal distribution of the electrons, 
bringing about positive and negative molecular parts. For example, a carbonyl group possesses 
a positively charged carbon and a negatively charged oxygen. This can be modelled through 
the assignment of partial charges to each atom or the assignment of dipole moments to each 
bond. These two means can produce similar results and the atomic charge model is preferred 
by most force fields. The interaction between two point charges is obtained using the Coulomb 
potential. 
Eelectro(RAB) = QA QB  (ε RAB)-1 
where Q is a point charge, R is the distance between points A and B and ε is a dielectric 
constant. The atomic charges are usually assigned through fitting to the electronic potential 
generated by electronic structure methods.  
Most force fields calculate Evdw and Eelectro for bonded atom pairs separated by three 
bonds or more and thus, the rotation barrier for the AD pair in an ABCD sequence is determined 
by Etorsion, Evdw and Eelectro terms together. Etorsion may be interpreted as a necessary correction 
for obtaining the correct rotation barrier once the non-bonded interactions have been 
determined. Some force fields also include Evdw for bonded atoms separated by one atom, 
called a Urey–Bradley term. In this case, the bending energy for a three atom sequence is a 
mixture of Ebend and Evdw.  
Validation of a FF is often made through checking the accuracy of reproduction for 
reference data, which may or may not be adopted in the actual parameterisation. The direct 
comparison of different force fields in accuracy is challenging due to their diverse use of 
reference data. Indeed, no FFs are perfect for universal applications, each of which has its 
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benefits and drawbacks. They can produce reliable simulated results for compounds that are 
structurally similar to those in the parameterisation sets, but may not be so for other systems. 
1.2.3 Electronic structure methods 
The interest of electron distribution in detail must be solved using quantum mechanics (QM). 
Electrons are very light particles and thus their behaviour cannot be predicted correctly using 
classical mechanics, even qualitatively. QM is centred on the solution to Schrödinger equation 
and the time-independent form is written as 
HΨ = EΨ 
where H represents the Hamiltonian operator, Ψ represents the wave function and E represents 
an energy function. When the solutions are produced without the use of experimental data, the 
methods are generally referred to as ab initio calculations, in contrast to semi-empirical methods 
(which use experimental parameters). The Born–Oppenheimer approximation – by which there 
is the neglect of the association between the nuclear and electronic movement – is the key to 
solving the Schrödinger equation. This permits the electronic part to be solved as function of the 
nuclear positions. Thus, the solution to the electronic Schrödinger equation, given a set of 
nuclear coordinates, requires the main part of computational effort. 
The dynamics of a many-electron system is extremely complicated and thus, this 
requires sophisticated computational methods. Independent particle models – one electron 
motion is independent of the other electrons – are introduced to simplify the system. This can 
be achieved either through the neglect of all other electrons but the most significant one, or 
through the consideration of the average effect accounting for all other electrons. The 
acceptable accuracy in electronic structure theory can only be obtained by the latter, namely 
Hartree-Fock (HF) theory. In this theory, each electron is described by an orbital and the total 
wave function is represented as a product of orbitals. The overall wave function must be 
antisymmetric (sign change for any two electrons exchange) and this can be achieved through 
the arrangement of the orbitals in a Slater determinant. The variational principle is used to 
obtain the optimal set of HF orbitals with the lowest energy under the condition that the wave 
function is a single Slater determinant. The molecular orbital shape describes the probability of 
an electron appearance, which includes the effects of the average all other electron repulsions 
and all nuclei attraction. Because the other electrons are described by their individual orbitals, 
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the solution to the HF equations must be determined by iteration. When a proper basis set is 
chosen for the molecular orbitals, the equations can be treated as a matrix for their eigenvalues 
and eigenvectors. Integrals of one and two-electron operators over basis functions, which are 
multiplied by density matrix elements, are the elements in the Fock matrix. Thus, the repeated 
diagonalisations of the Fock matrix can be used to solve the HF equations in a basis set. Based 
on the HF model, if additional approximations are adopted, this brings out semi-empirical 
methods. Or if additional determinants are incorporated, this produces models which can be 
resolved towards the exact solution of the electronic Schrödinger equation (Jensen, 2007).  
Semi-empirical methods are derived from the HF model through the neglect of all 
integrals associated with greater than two nuclei in the original Fock matrix. Such 
approximations alone will result in a poor model due to the inherently limited accuracy of the HF 
model. Semi-empirical methods further parameterise the remaining integrals with a reference to 
experimental data, particularly for molecular geometries and energies. These methods are 
computationally more cost-effective than the ab initio HF method but are limited to the 
parameterised systems. 
HF theory neglects the correlation between electrons and further improvement in 
accuracy is required to include the effect. Because HF is the optimal single-determinant wave 
function, methods incorporating the electron correlation require a multi-determinant wave 
function. Such methods are computationally more expensive but can provide systematically 
improving results towards the exact solution of the Schrödinger equation.  
Density functional theory (DFT) using the Kohn–Sham model (Kohn and Sham, 1965) 
can be interpreted as an improved method (over HF theory) – the electron correlation effect is 
modelled as a function of the electron density. DFT is also an independent-particle model but 
provides significantly superior results with the same computational cost as HF methods. The 
main drawback of DFT is no systematic approach for improving results towards the exact 
solution.  
1.2.4 Molecular dynamics 
Molecular Dynamics (MD) methods produce a series of time-dependent points in a trajectory 
using Newton’s second equation in a series of finite time steps, evolving an initial set of atomic 
coordinates and velocities. A typical time step is one femtosecond (10-15 s) and if a total 
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simulation time is one nanosecond (10-9 s), this already requires a million computational steps. 
Such simulation time is significantly shorter than many naturally occurring phenomena and MD 
methods often only sample a part of phase space near the starting point. Moreover, MD 
methods simulate the physical configuration changes and thus are susceptible to becoming 
trapped in conformational states associated with local energy minima. 
MD simulations must run in Cartesian coordinates, and constraints are somewhat 
difficult to be enforced in the system. The simulations require small time steps and often 
compute relatively unimportant bond stretching and angle bending motions with a significant 
computational expenditure. Also, energy barriers are hard to overcome by MD simulations due 
to an inherent force being generated to take the system back towards minima and working 
against movements to states of higher potential energy. In theory, MD is deterministic – two 
simulations with the same starting conditions should produce the same trajectory. However, 
because different computers (and compilers) generate different round-off errors, the numerical 
errors arising in each time step will gradually accumulate to become significant. Thus, in 
practice, MD simulations are non-deterministic and show chaotic behaviour for timescales 
greater than fifty picoseconds (10-12 s). MD simulations include both atomic velocities and time 
dependence and thus models for time-dependent events, such as transport and diffusion 
phenomena, are appropriate. The implementation of MD simulations requires calculations for 
the energy and the force (first derivative of the energy) on all particles in the system. 
Parameterised energy functions used in force field methods can compute these two terms 
readily. Because the motions of all particles are different in each time step, the energy function 
(and gradient) must be updated accordingly. 
The non-deterministic behaviour of MD simulations in practice may be regarded as a 
potential problem. In fact, the chaotic behaviour may assist in a more complete sampling to 
obtain a representative sample of the phase space. However, the random and chaotic features 
in simulations can lead to troublesome identification of errors in programming. The validation of 
a novel simulation program cannot be made readily through the comparison of exact numbers 
with another program – the same program run on different types of machines may not generate 
the same results. The inherent statistical errors in all simulations may cover the part of small 
systematic errors generated by program errors. Thus, development of simulation packages 
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must be made carefully through monitoring many different quantities to ensure the validation 
(van Gunsteren and Mark, 1998). 
A simulation can be described by quantities, such as number of particles (N), pressure 
(P), volume (V), temperature (T), total energy (E), chemical potential (CP), and some of these 
are correlated with each other. For a system with a constant N, either P or V can be fixed, but 
not both. Similarly, either the T or E can be fixed, but not both, and a constant CP cannot co-
exist with a constant N. The ensemble is labelled following the fixed quantities. A MD simulation 
conserves energy and thus, is the natural NVE type, but other types of ensembles can also be 
generated through suitable algorithms. 
The results of simulations and experiments require the average over the number of 
molecules for a period of time but their averaging scales tend to be significantly different from 
each other. Thus, the direct comparison between the computed quantities and the experiments 
is not entirely clear. For instance, an IR spectrum records the average over a sample composed 
of perhaps a thousand molecules for ten femtoseconds. On the other hand, a simulation might 
simulate the molecular motions of perhaps a hundred molecules for one nanosecond. The 
assumption of the ergodic hypothesis states that the average over a large number of particles 
for a short time is equivalent to the average over a small number of particles for a long time – 
ensemble-averaging is equivalent to time-averaging. In other words, the ergodic hypothesis 
implies that wherever a system begins, any other point in phase space is possibly reached. MD 
is a time-averaging method.  
1.2.5 Solvation models 
Evaluation of the effect on the environment, such as a solvent, is one of important aspects in 
computational chemistry. Methods for the evaluation of the solvent effect can generally be 
categorised into two types – 1. explicit solvent models including the individual solvent molecules; 
2. implicit solvent models treating the solvent as a continuous medium (Jensen, 2007). 
Combinations of these two types are also feasible – for instance, first solvation shell consists of 
explicit solvent molecules and the rest is treated using a continuum model. They may be 
subdivided based on the use of classical or quantum mechanical computation. The most crucial 
solvent is water and most developed methods are centred on this. The impacts of solvation can 
be divided into two major parts: 1. Non-specific (long-range) solvation including polarisation and 
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dipole orientation; 2. Specific (short-range) solvation including hydrogen bonds, van der Waals 
interaction, solvent shell structure, solvent–solute dynamics, charge transfer effects and 
hydrophobic effects (entropy effects). These effects bring out a screening of charge 
interactions – the (macroscopic) dielectric constant is greater than one. The microscopic 
interactions, depending on the nature of solvent molecules, mainly occur in the first solvation 
shell (even though the second solvation shell might also be important for highly charged ions).  
In principle, a molecular model using simulation methods with periodic boundary 
conditions enables one to take into account all of the above solvent effects and the quality of the 
results depends on the realistic level of the description for the solvent-solute and solvent-solvent 
interactions. A realistic model requires many explicit solvent molecules and thus, force field 
methods are generally preferred in practice. Because the use of polarisable force fields is not 
yet common, there is a significant deficiency in the modelling of non-specific solvation. Quantum 
mechanical methods, such as Car-Parrinello MD (http://www.cpmd.org/) using density functional 
theory for the description of the interaction, are substantially more computationally expensive 
and thus, only a limited sampling of the phase space can be provided. These methods can take 
into account the polarisation but often provide poor description of van der Waals interactions. 
Semi-empirical electronic structure methods are generally insufficiently accurate for the 
calculation of intermolecular potentials. 
Non-specific solvation can alternatively be modelled by treating the solvent as a 
homogeneous medium with a dielectric constant (ε), in which a solute is placed in an adequately 
shaped cavity, namely continuum solvation models (Roux and Simonson, 1999). The solvation 
energy can be divided into three parts: 1. cavity generation in the medium requires energy; 2. 
dispersion/repulsion interactions between the solute and solvent; 3. the induced electrostatic 
charge interactions between the solute and solvent. There are five main factors affecting the 
computational results of the models: 1. the size and shape of the cavity; 2. the algorithm of 
dispersion/repulsion contributions; 3. the algorithm of the solute charge distribution; 4. the 
molecular or quantum mechanical algorithm for the solute; 5. the algorithm of the dielectric 
medium (Jensen, 2007). In general, this type of model can mimic non-specific solvation 
reasonably but cannot mimic the specific solvation which appears in the first solvation sphere. 
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1.3 Aim of project 
To explore the use of quantum or molecular mechanical and molecular dynamic simulations in 
modelling the pKa, iron binding affinity and hydration properties of 3-hydroxypyridin-4-ones, with 
the overall aim of facilitating a rational design of therapeutic Fe3+ chelating agents. 
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Chapter 2 Experimental Fe3+ Stability Constants Determination 
2.1 Introduction 
In the design and clinical development of therapeutic iron chelators, it is crucial to know, or to be 
able to reliably predict stability constants, which quantify their binding affinity for H+ and Fe3+. 
With the aim of obtaining data for prediction validation, the stability constants of thirty-three 
HPOs and one 8-hydroxyquinoline-2-carboxylic acid (8HQC, a tridentate ligand) were 
experimentally determined.  
2.2 Methods 
Stability constants were experimentally determined by use of an automated titration system: 1. 
sample preparation; 2. calibration of pH meter; 3. load of sample into the system (25 oC, 0.1 M 
KCl ionic strength); 4. export of UV spectra data into pHab (Gans et al., 1999) to obtain 
experimental values; 5. export of experimental values into HySS (Alderighi et al., 1999) to 
obtain speciation plots and pFe3+ values. Full details are provided in Kong (2008) and Kong et 
al., (2006). The key factors of starting titration pH value and the molar ratios of ligand (L) : metal 
ion (Fe3+) when determining Fe3+ affinity constants were here taken as the HPO carbonyl pKa 
value, the lower pKa value of the two HPO oxygens coordinating Fe3+, minus 2 if possible 
(according to Henderson-Hasselbalch equation), and a 10 : 1 molar ratio of L : Fe3+. (The 
reasons for these choices are discussed in Chapter 5.) For HPOs possessing more than 2 pKa 
values, the assignment of pKa values (to the two HPO oxygens, directly related to experimental 
stability constants for Fe3+) is an additional issue and the QM calculations reported in Chapter 3 
proved valuable in this assignment. 
2.3 Results 
The UV/Vis spectra and corresponding speciation plots for CP20 (a typical HPO with two pKa 
values) are presented in Figure 2-1. For pKa titration, an isosbestic point at λ 290 nm occurs 
when [LH] of CP20 deprotonates. [LH2]+ dominates in solution from pH 1 to pH 3. [LH] 
dominates in solution from pH 5 to pH 8. [L]- dominates in solution from pH 11 to pH 13. The two 
pKa values (9.83 and 3.61) were determined from curve fitting analysis of the spectra. For Fe3+ 
affinity titration, with a 10 : 1 molar ratio of L : Fe3+, two isosbestic points occur in the spectral 
series: one at λ 613 nm, corresponding to the formation of [Fe3+L2]+ and the other at λ 506 nm, 
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corresponding to the formation of [Fe3+L3]. [Fe3+L1]2+ dominates in solution from pH 0.5 to pH 
1.5. [Fe3+L2]+ dominates in solution from pH 2 to pH 3. [Fe3+L3] dominates in solution from pH 4 
through to pH 8. The log K1, log β2, log β3 values (15.01, 27.39 and 37.35, respectively) were 
determined from curve fitting analysis of the spectra. pFe3+ (20.59) was determined through 
export of the stability constants reported above into HySS.  
The UV/Vis spectra and corresponding speciation plots for CP511 (a HPO with two pKa 
values and strong intramolecular hydrogen bonding (Piyamongkol et al., 2010)) are presented in 
Figure 2-2. For pKa titration, two isosbestic points occur in the spectral series: one at λ 299 nm, 
corresponding to the formation of [LH] and the other one at λ 310 nm, corresponding to the 
formation of [L]-. [LH2]+ dominates in solution from pH 1 to pH 2. [LH] dominates in solution from 
pH 3 to pH 6. [L]- dominates in solution from pH 7 to pH 9. The two pKa values (6.71 and 2.42) 
were determined from curve fitting analysis of the spectra. For Fe3+ affinity titration, with a 10 : 1 
molar ratio of L : Fe3+, two isosbestic points occur in the spectral series: one at λ 600 nm, 
corresponding to the formation of [Fe3+L2]+ and the other at λ 505 nm, corresponding to the 
formation of [Fe3+L3]. [Fe3+L1]2+ dominates in solution from pH 0 to pH 0.5. [Fe3+L2]+ dominates 
in solution from pH 1 to pH 1.5. [Fe3+L3] dominates in solution from pH 2 through to pH 8. The 
log K1, log β2, log β3 values (12.03, 22.38 and 31.26, respectively) were determined from curve 
fitting analysis of the spectra. pFe3+ (21.55) was determined through export of the stability 
constants reported above into HySS. 
The UV/Vis spectra and corresponding speciation plots for CP417 (a HPO with three 
pKa values) are presented in Figure 2-3. For pKa titration, two isosbestic points occur in the 
spectral series: one at λ 302 nm, corresponding to the formation of [LH] and the other one at λ 
305 nm, corresponding to the formation of [L]-. [LH3]2+ dominates in solution from pH 0 to pH 1. 
[LH2]+ dominates in solution from pH 2.5 to pH 5. [LH] dominates in solution from pH 7.5 to pH 
10. [L]- dominates in solution from pH 11 to pH 13. The three pKa values (10.47, 6.71 and 2.03) 
were determined from curve fitting analysis of the spectra. For Fe3+ affinity titration, with a 10 : 1 
molar ratio of L : Fe3+, two isosbestic points occur in the spectral series: one at λ 601 nm, 
corresponding to the formation of [Fe3+L2]+ and the other at λ 503 nm, corresponding to the 
formation of [Fe3+L3]. [Fe3+L1]2+ dominates in solution from pH 0.3 to pH 0.9. [Fe3+L2]+ dominates 
in solution from pH 1 to pH 1.8. [Fe3+L3] dominates in solution from pH 2 through to pH 8. The 
log K1, log β2, log β3 values (10.98, 20.54 and 28.78, respectively) were determined from curve 
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fitting analysis of the spectra. pFe3+ (19.07) was determined through export of the stability 
constants reported above into HySS. Members of entire HPO series have similar UV/Vis spectra 
for their [Fe3+L1]2+, [Fe3+L2]+ and [Fe3+L3] species. The stability constants of all thirty-three HPOs 
experimentally determined in this study are presented in Table 2-1 and the additional UV/Vis 
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Figure 2-1 UV/Vis spectra and corresponding speciation plots for CP20. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 1176.8 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 456.6 μM 
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Figure 2-2 UV/Vis spectra and corresponding speciation plots for CP511. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 879.7 μM over the pH range 1-8; 
(c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 445.4 μM and 
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Figure 2-3 UV/Vis spectra and corresponding speciation plots for CP417. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 930.8 μM over the pH range 1-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 363.4 μM 
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a Hydroxyl group, b carbonyl group, c third functional group, the assignments were made using the QM method reported 
in Chapter 3; d the stability constants for Fe3+ were determined approximately because the third deprotonated functional 
group influences the spectra significantly (see Appendix A). 
HPOs R1 R2 R5 R6 
CP20 −CH3 −CH3 −H −H 
CP28 −H −CH3 −H −H 
CP38 −C2H4COOH −CH3 −H −H 
CP40 −C2H4OH −CH3 −H −H 
CP70 −H −H −H −CH3 
CP102 −C2H4OH −C2H5 −H −H 
CP110 −C2H4COOH −C2H5 −H −H 
CP111 −C3H6COOH −C2H5 −H −H 
CP352 −C2H4OH −CH(C6H5)OH −H −CH3 
CP359 −C2H5 −CH2OH −H −H 
CP364 −CH3 −CH2OH −H −H 
CP365 −C2H5 −CHCH3OH −H −H 
CP366 −C3H6OH −CH2OH −H −H 
CP370 −C2H5 −CH2OCH3 −H −CH3 
CP372 −C3H6OH −CHCH3OH −H −H 
CP374 −CH3 −CHC2H5OH −H −CH3 
CP375 −CH3 −CHC2H5OCH3 −H −CH3 
CP414 −CH3 −CH2(NC5H10) −H −CH3 
CP417 −CH3 −CH2(NC5H10) −H −CH2OH 
CP510 −CH3 −H −H −CONHCH3
CP511 −H −CONHCH3 −H −CH3 
CP529 −H −CONHCH3 −H −H 
CP545 −H −CONHC2H4OH −H −H 
CP616 −H −CH3 −CH3 −H 
CP751 −CH3 −CH3 −CH3 −H 
YMF1 −H −CHCF3OH −H −H 
YMF3 −H −F −F −F 
YMF4 −H −F −H −F 
YMF6 −H −F −H −H 
YMF13 −H −F −CH3 −H 
YMMO1 −CH3 −CH3 −OCH3 −H 
CN116 −CH[CH(CH3)2]CH2OH −CH3 −H −H 
CN128 −CH(C6H5)CH2OH −CH3 −H −H 
HPOs pKa1a pKa2b pKa3c Log K1 Log β2 Log β3 pFe3+ 
CP20 9.83 3.61  15.01 27.39 37.35 20.59 
CP28 9.70 3.69  14.49 26.46 35.96 19.59 
CP38 9.88 3.09 3.94 14.62 26.65 36.36 19.46 
CP40 9.72 3.39  14.61 26.67 36.34 19.92 
CP70 9.33 3.71  14.09 25.80 35.25 19.98 
CP102 9.80 3.37  14.69 26.75 36.35 19.69 
CP110 9.81 3.26 4.46 14.78 26.79 36.40 19.71 
CP111 9.90 3.59 5.84 14.58 26.60 36.03 19.06 
CP352 8.56 2.74  13.02 24.03 32.95 19.92 
CP359 9.20 2.99  14.26 26.15 35.94 21.06 
CP364 9.19 3.06  14.28 26.20 36.01 21.16 
CP365 8.93 3.15  14.15 25.68 34.97 20.88 
CP366 9.06 3.02  13.82 25.32 34.84 20.35 
CP370 9.14 3.00  14.29 26.09 35.66 20.95 
CP372 9.15 2.97  14.29 26.06 35.56 20.82 
CP374 9.13 3.48  14.41 26.13 35.62 20.94 
CP375 9.65 3.29  14.50 26.49 36.27 20.05 
CP414 6.96 2.43 10.68 11.59 21.48 30.03 20.16 
CP417 6.71 2.03 10.47 10.98 20.54 28.78 19.07 
CP510 8.03 2.39  12.20 22.63 31.34 19.71 
CP511 6.71 2.42  12.03 22.38 31.26 21.55 
CP529 6.43 2.08  11.45 21.53 30.25 20.65 
CP545 6.27 1.97  11.32 21.19 29.48 19.92 
CP616 10.27 3.56  15.17 27.39 36.83 18.78 
CP751 10.32 3.37  15.51 28.12 37.93 19.71 
YMF1 8.26 2.65  13.05 24.02 33.01 20.80 
YMF3 9.95 4.21  15.06 26.96 35.89 18.80 
YMF4 10.51 5.78  16.52 29.33 38.66 19.88 
YMF6d 10.63 1.06 6.54 14.08 26.16 36.69 17.54 
YMF13d 11.10 1.42 6.63 14.44 26.97 37.71 17.16 
YMMO1 9.90 3.36  14.80 26.81 36.08 19.13 
CN116 9.86 3.35  14.82 27.05 36.82 19.98 
CN128 9.90 3.26  14.78 27.00 36.79 19.83 
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The UV/Vis spectra and corresponding speciation plots for 8-hydroxyquinoline-2-carboxylic acid 
(8HQC, a tridentate) are presented in Figure 2-4. For pKa titration, three isosbestic points occur 
in the spectral series: one at λ 393 nm, corresponding to the formation of [LH2], the second one 
at λ 355 nm, corresponding to the formation of [LH]- and the third one at λ 331 nm, 
corresponding to the formation of [L]2-. [LH3]+ dominates in solution from pH 0 to pH 0.3. [LH2] 
dominates in solution from pH 1 to pH 3. [LH]- dominates in solution from pH 6 to pH 8. [L]2- 
dominates in solution from pH 11 to pH 13. The three pKa values (9.66, 3.91 and 0.62) were 
determined from curve fitting analysis of the spectra. For Fe3+ affinity titration, with a 10 : 1 
molar ratio of L : Fe3+, one isosbestic points occur at λ 836 nm when [Fe3+L2]- forms. [Fe3+L1]+ 
dominates in solution from pH 0.5 to pH 1.5. [Fe3+L2]- dominates in solution from pH 2 through to 
pH 8. The log K1 and log β2 values (14.14 and 26.46, respectively) were determined from curve 
fitting analysis of the spectra. pFe3+ (17.73) was determined through export of the stability 
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Figure 2-4 UV/Vis spectra and corresponding speciation plots for 8HQC. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 20.5 μM over the pH range 0.5-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 1747.7 

















































































- 34 - 
2.4 Discussion 
In general, different substituents around the HPO aromatic ring can affect the pKa values of the 
two 3,4-oxygen atoms significantly, thereby influencing their affinity for Fe3+. If methyl or alkyl 
groups are attached to the HPO ring, their electron donating effects can generally increase the 
pKa values of the two oxygen atoms. If amido groups are attached to the HPO ring, their 
electron withdrawing effects and potential formation of intramolecular hydrogen bonding can 
generally decrease the pKa values of the two oxygen atoms. If hydroxymethyl groups are 
attached to the HPO ring, they can result in the same effects as amido groups to decrease the 
pKa values of the two oxygen atoms. However, the influence of hydroxymethyl groups is 
generally weaker than that of amido groups. If fluorine atoms are attached to the HPO ring, their 
strong electron withdrawing effects can generally decrease the pKa values of the two oxygen 
atoms.  
Based on these general observations, it is clear that a high electron density on the ligating 
oxygen atoms leads to both an increase in the pKa values of the ligand and its affinity for Fe3+ in 
the absence of competitors. 
The experimental errors incurred in pKa determination are mainly contributed by 
deficiencies in the pH meter employed, for example device ageing, electrode instability, and 
CO2 disturbance (Kong, 2008). Such deficiencies are estimated to give rise to systematic errors 
of the order of ± 0.1 log unit. The experimental errors incurred in (Fe3+) log K1, log β2 and log β3 
determinations for HPOs arise mainly as a result of sample concentration errors and errors in 
the measured hydroxyl and carbonyl pKa values (particularly the former) (Kong, 2008). Such 
errors are estimated to be of the order of ± 0.15 log unit, ± 0.31 log unit and ± 0.41 log unit, 
respectively (assuming errors on the determined pKa values of ± 0.1 log unit and a sample 
concentration error of ± 10 %).  
The 10 : 1 molar ratio of L : Fe3+ condition was adopted to improve the accuracy of the log 
K1 experimental determination. The discussion relating to this modification of the standard 
condition and the general reliability of the experimental log K1 values is presented in Chapter 5. 
Using these titration techniques and the QM calculations (Chapter 3) to assign pKa values, 
many previously determined and published Fe3+ affinity constants were corrected. These 
corrections are reported in Chapters 3 and 5. 
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Chapter 3 Prediction of HPO Hydroxyl pKa Values Using QSPR 
and Quantum Mechanical Static Calculations with Implicit 
Solvent Models 
3.1 Introduction 
pKa is one of key physicochemical properties for Fe3+ chelators, strongly associated with Fe3+ 
affinity (log β and pFe3+) (Hider and Hall, 1991). In order to predict pKa values rapidly and 
reliably, this was made by means of QSPR and QM static calculations using thermodynamic 
cycles or regression models with implicit solvent models. The assignments of HPO pKa values 
reported in Chapter 2 were assisted using the QM static calculations described here for the 
energy comparison of their deprotonated tautomers. The main results of this chapter are 
published in Chen et al. (2012a). 
3.2 Methods 
3.2.1 Development of a prediction method based on QM static calculations 
One way of predicting pKa values is to calculate the free energy in solution (∆G*soln) of the 
protonation process from thermodynamic cycles (Schemes 1 and 2) using the relationship:  
pKa = ∆G*soln [RT ln(10)]-1 
where R is the gas constant (1.99 cal K-1mol-1), T is the absolute temperature and Ka is the 
molar equilibrium constant of the acid. 
 Scheme 3-1 presents the simplest thermodynamic cycle to predict pKa values and can 
also be referred to as the direct or absolute method (Ho and Coote, 2010). This method 
includes accurate gas-phase acidity measurements, from either experimental data or computed 
by high level ab initio or density functional theory (DFT) methods, and solvation free energies 
gained from different solvent models. In addition, this scheme requires the experimental 
solvation free energy of the proton, ∆G*solv (H+) = -265.9 kcal mol-1 (Ho and Coote, 2010). In 
general, the gas-phase acidity constant computed via high level ab initio or DFT methods is 
believed to be reasonably accurate (with calculated and experimental values typically within ± 2 
kcal mol-1) (Foresman and Frisch, 1996). However, there are no gas phase acidity data 
available for 3-hydroxypyridin-4-ones (HPOs) and only their pKa values in 0.1M KCl at 25˚C are 
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available. Dielectric continuum solvent models, treating the solvent as a continuum of uniform 
dielectric constant (ε) and placing the solute into a cavity within the solvent (Foresman and 
Frisch, 1996), are thought to have significant errors associated with the calculation of solvation 
free energies, particularly if the solutes of interest are ionic species or involve hydrogen bond 
acceptor and/or donor groups (Ho and Coote, 2010). Again, there are no suitable solvation free 
energy data for HPOs. 
 
Scheme 3-1 pKa prediction via the direct/absolute method (Ho and Coote, 2010). 
 In order to cancel the systematic errors, mainly related to the solvation free energies, 
the proton exchange scheme (Scheme 3-2) was introduced. This scheme includes a reference 
acid (HRef) and although the accuracy of the method is sensitive to the choice of HRef, the 
proton exchange scheme normally produces better pKa predictions than the direct method (Ho 
and Coote, 2010). 
 
Scheme 3-2 pKa prediction via the proton exchange scheme, HRef: a reference acid (Ho and Coote, 2009). 
 In the work reported here, Gaussian 09 (Frisch et al., 2009) was utilised to calculate 
optimised geometries, without symmetry constraints and with force constants calculated at each 
step and their corresponding free energies obtained from Gaussian 09 outputs. Unless 
otherwise indicated, all the solvation free energies were derived through direct optimisation in 
solvent models. The optimised structures were verified as corresponding to a local minimum – a 
stationary point on the potential energy surface – by checking that there were no imaginary 
frequencies in the output. In order to reach a global (or nearly global) minimum structure, before 
running Gaussian 09 optimisation, a conformation search function at the semi-empirical AM1 
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level in HyperChem Release 8 (http://www.hyper.com/) was carried out for all the molecules 
studied.  
Initially, the methods were developed using the experimentally determined hydroxyl pKa 
values of fifteen HPOs (Table 3-1). In order to compare the accuracy of the different methods, 
the correlation coefficient (r) for the regression between predicted and experimental values and 
their mean and standard deviation of absolute deviations (|M| and |S|) were used. 
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HPOs R1 R2 R5 R6 
CP20 −CH3 −CH3 −H −H 
CP21 −C2H5 −CH3 −H −H 
CP23 −CH(CH3)2 −CH3 −H −H 
CP60 −CH3 −H −H −H 
CP61 −C2H5 −H −H −H 
CP68 −CH3 −CH3 −H −CH3 
CP69 −CH3 −H −H −CH3 
CP90 −H −H −H −H 
CP93 −CH3 −C2H5 −H −H 
CP94 −C2H5 −C2H5 −H −H 
CP99 −H −C2H5 −H −H 
CP502 −CH3 −CONHCH3 −H −CH3 
CP511 −H −CONHCH3 −H −CH3 
CP40 −C2H4OH −CH3 −H −H 
CP102 −C2H4OH −C2H5 −H −H 
CP359 −C2H5 −CH2OH −H −H 
CP360 −CH3 −CH2OH −H −CH3 
CP361 −CH3 −CHCH3OH −H −CH3 
CP364 −CH3 −CH2OH −H −H 
CP365 −C2H5 −CHCH3OH −H −H 
CP366 −C3H6OH −CH2OH −H −H 
CP369 −C2H5 −CH2OH −H −CH3 
CP372 −C3H6OH −CHCH3OH −H −H 
CP374 −CH3 −CHC2H5OH −H −CH3 
CP508 −CH3 −CON(CH3)2 −H −CH3 
CP509 −H −CON(CH3)2 −H −CH3 
CP510 −CH3 −H −H −CONHCH3
CP513 −CH3 −CONHC2H5 −H −CH3 
CP514 −C2H5 −CONHCH3 −H −CH3 
CP528 −H −CONH2 −H −H 
CP545 −H −CONHC2H4OH −H −H 
YMF1 −H −CHCF3OH −H −H 
YMF5 −H −H −F −H 
YMF7 −CH3 −F −H −H 
YMF8 −C2H5 −F −H −H 
YMF10 −H −F −CONHCH(CH3)CONHCH3 −H 
YMF13 −H −F −CH3 −H 
YMF14 −CH3 −F −CH3 −H 
YMF15 −CH3 −H −F −H 
YMF16 −C2H5 −H −F −H 
YMF17 −CH3 −CH3 −F −H 
YMF18 −H −F −H −CH3 
YMF19 −H −F −CH3 −CH3 
YMF21 −H −H −F −CH3 
YMF22 −H −CH3 −F −H 
YMF24 −C3H7 −F −H −H 
YMF25 −C3H7 −H −F −H 
YMF26 −CH(CH3)2 −H −F −H 
YMF29 −H −F −CONHCH3 −H 
YMF31 −H −F −CONH2 −H 
YMF32 −H −F −CON(CH3)2 −H 
YMF33 −C4H9 −F −H −H 
CP38 −C2H4COOH −CH3 −H −H 
CP110 −C2H4COOH −C2H5 −H −H 
CP111 −C3H6COOH −C2H5 −H −H 
CP352 −C2H4OH −CH(C6H5)OH −H −CH3 
CP362 −CH3 −CH2OCH3 −H −CH3 
CP363 −CH3 −CH(CH3)OCH3 −H −CH3 
CP414 −CH3 −CH2(NC5H10) −H −CH3 
CP417 −CH3 −CH2(NC5H10) −H −CH2OH 
YMF3 −H −F −F −F 
YMF4 −H −F −H −F 
YMF6 −H −F −H −H 
CP751 −CH3 −CH3 −CH3 −H 
YMF11 −H −CONHCH(CH3)CONHCH3 −F −H 
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Table 3-1 continued 
HPOs ∆G*calculated (G*calculated for LH, L-) (Hartree)i Hydroxyl pKa 
CP20a 0.4598 (-477.2887, -476.8289) 9.76 (9.76)b 
CP21a 0.4609 (-516.5787, -516.1179) 10.04 (9.82)b 
CP23a 0.4610 (-555.8663, -555.4053) 10.07 (9.90)b 
CP60a 0.4559 (-437.9967, -437.5408) 8.81 (8.79)b 
CP61a 0.4573 (-477.2883, -476.8311) 9.15 (8.87)b 
CP68a 0.4615 (-516.5789, -516.1174) 10.19 (10.13)b 
CP69a 0.4575 (-477.2890, -476.8316) 9.20 (9.12)b 
CP90a 0.4567 (-398.7130, -398.2563) 9.01 (9.01)b 
CP93a 0.4598 (-516.5744, -516.1146) 9.77 (9.85)b 
CP94a 0.4604 (-555.8647, -555.4043) 9.92 (9.86)b 
CP99a 0.4595 (-477.2971, -476.8376) 9.70 (9.81)b 
CP502a 0.4554 (-685.2680, -684.8126) 8.69 (8.44)b 
CP511a 0.4471 (-646.0009, -645.5538) 6.66 (6.66)b 
CP40a 0.4595 (-591.7952, -591.3356) 9.70 (9.72)c 
CP102a 0.4600 (-631.0816, -630.6216) 9.81 (9.76)c 
CP359 0.4570 (-591.7920, -591.3350) 9.08 (9.05)d 
CP360 0.4572 (-591.7924, -591.3352) 9.14 (9.42)d 
CP361 0.4539 (-631.0809, -630.6270) 8.33 (8.97)d 
CP364 0.4567 (-552.5020, -552.0453) 9.02 (9.11)d 
CP365 0.4537 (-631.0811, -630.6275) 8.27 (8.74)d 
CP366 0.4571 (-706.2979, -705.8408) 9.12 (9.11)d 
CP369 0.4567 (-631.0810, -630.6243) 9.00 (9.38)d 
CP372 0.4536 (-745.5875, -745.1339) 8.24 (8.69)d 
CP374 0.4540 (-670.3692, -669.9152) 8.36 (8.98)d 
CP508 0.4546 (-724.5470, -724.0923) 8.51 (8.14)e 
CP509 0.4532 (-685.2715, -684.8183) 8.16 (8.20)e 
CP510 0.4537 (-645.9762, -645.5224) 8.29 (8.05)e 
CP513 0.4555 (-724.5588, -724.1033) 8.72 (8.45)e 
CP514 0.4554 (-724.5566, -724.1012) 8.69 (8.41)e 
CP528 0.4459 (-606.7032, -606.2574) 6.36 (6.38)e 
CP545 0.4448 (-721.2113, -720.7665) 6.09 (6.27)e 
YMF1 0.4529 (-850.2826, -849.8297) 8.08 (8.19)f 
YMF5 0.4537 (-497.9583, -497.5046) 8.27 (8.23)f 
YMF7 0.4525 (-537.2402, -536.7877) 7.98 (7.72)f 
YMF8 0.4531 (-576.5310, -576.0779) 8.13 (7.72)f 
YMF10 0.4609 (-952.7847, -952.3238) 10.04 (9.97)f 
YMF13 0.4642 (-536.8056, -536.3414) 10.85 (11.28)f 
YMF14 0.4543 (-576.5339, -576.0797) 8.42 (8.35)f 
YMF15 0.4534 (-537.2414, -536.7880) 8.21 (8.18)f 
YMF16 0.4539 (-576.5335, -576.0796) 8.33 (8.26)f 
YMF17 0.4571 (-576.5342, -576.0771) 9.12 (9.08)f 
YMF18 0.4639 (-536.8085, -536.3446) 10.77 (11.08)f 
YMF19 0.4658 (-576.0979, -575.6320) 11.25 (11.56)f 
YMF21 0.4547 (-537.2553, -536.8006) 8.52 (8.69)f 
YMF22 0.4559 (-537.2553, -536.7994) 8.82 (8.93)f 
YMF24 0.4531 (-615.8196, -615.3665) 8.12 (7.89)f 
YMF25 0.4538 (-615.8220, -615.3682) 8.30 (8.12)f 
YMF26 0.4541 (-615.8226, -615.3685) 8.38 (8.12)f 
YMF29 0.4603 (-705.5090, -705.0487) 9.90 (9.95)f 
YMF31 0.4600 (-666.2261, -665.7661) 9.81 (9.96)f 
YMF32 0.4612 (-744.7795, -744.3183) 10.11 (10.26)f 
YMF33 0.4534 (-655.1086, -654.6553) 8.20 (7.79)f 
CP38 0.4610 (-704.7183, -704.2573) 10.08 (9.88)g 
CP110 0.4613 (-744.0059, -743.5446) 10.14 (9.81)g 
CP111 0.4612 (-783.2938, -782.8326) 10.12 (9.90)g 
CP352 0.4574 (-937.2790, -936.8216) 9.19 (8.56)g 
CP362 0.4591 (-631.0699, -630.6107) 9.61 (9.31)g 
CP363 0.4600 (-670.3575, -669.8975) 9.88 (9.58)g 
CP414 0.4477 (-767.6005, -767.1527) 6.81 (6.96)g 
CP417 0.4461 (-842.8134, -842.3673) 6.43 (6.71)g 
YMF3 0.4589 (-696.0163, -695.5574) 9.55 (9.95)g 
YMF4 0.4619 (-596.7734, -596.3114) 10.30 (10.32)g 
YMF6 0.4629 (-497.5130, -497.0500) 10.54 (10.63)g 
CP751 0.4615 (-516.5825, -516.1210) 10.18 (10.32)g 
YMF11 0.4427 (-953.2248, -952.7821) 5.58 (5.15)h 
a the first fifteen HPOs were used to test different existing pKa prediction methods; experimental pKa values taken from b 
Kong (2008); c Rai et al. (1998); d Liu et al. (1999); e Piyamongkol et al. (2010); f Ma et al. (2012); g this study obtained 
from Chapter 2; h Kong (Chen et al., 2012a); I∆G*calculated: the calculated free energy differences between LH and L- 
using B3LYP/6-31+G(d)/CPCM(Pauling radii, water as solvent) (G*calculated: the calculated free energy); 1 Hartree = 
627.5095 kcal mol-1. 
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 Test 1: the direct method was applied using model chemistry B3LYP/6-31+G(d), a DFT 
method widely used for ionic species (Foresman and Frisch, 1996) and CPCM solvent model in 
water with default cavity radii, UFF radii, denoted as B3LYP/6-31+G(d)/CPCM(UFF radii, water 
as solvent). The pKa predictions achieved were reasonably accurate (giving r2 = 0.90, |M| = 5.50 
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Figure 3-1 Result of Test 1, hydroxyl pKa values predicted following the procedure presented in Scheme 
3-1 with free energies computed using a B3LYP/6-31+G(d) basis set and the CPCM default model to treat 
solvent effects. 
 Test 2: the proton exchange scheme (using CP90 as a reference acid) was 
implemented using the same model chemistry and solvent model as employed in Test 1. The 
pKa predictions achieved in this scheme were rather better than those obtained using the direct 
method (giving r2 = 0.90, |M| = 1.30 and |S| = 1.17, Figure 3-2).  
The tests using the proton exchange scheme via higher level model chemistries for 
solvation free energies were also explored and the results are indicated in Table 3-2. In these 
tests, the solvation free energies were calculated from single-point energy calculations, rather 
than from optimisations. From Tests 3 and 4, it was established that the changes in the basis 
set or DFT functional do not give significantly better predictions than those achieved in Test 2. 
From Tests 5, 6 and 7, compound methods (CBS-X or Gaussian-X) (Foresman and Frisch, 
1996) were found to be incapable of calculating pKa values for some or all of the fifteen HPOs 
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owing to computer resource limitations. Moreover, these methods require much more computing 
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Figure 3-2 Result of Test 2, the proton exchange scheme (using CP90 as a reference acid) was applied 
using the same model chemistry as Test 1. 
 Table 3-2 Results of tests using the proton exchange scheme via higher level model chemistries for 
solvation free energies. 
Tests Model Chemistry Results 
3a B3LYP/6-311++G(3df,3pd)/CPCM(UFF radii, water as solvent)//B3LYP/6-31+G(d) There are no significant improvements compared to Test 2. 
4 B971/6-311++G(3df,3pd)/CPCM(UFF radii, water as solvent)//B3LYP/6-31+G(d) There are no significant improvements compared to Test 2. 
5 CBS-4M/CPCM(UFF radii, water as solvent)//B3LYP/6-31+G(d) 
Some of the compounds could not be modelled using the Windows 
Gaussian 09 system owing to computer resource limitations. 
6 CBS-4Q/CPCM(UFF radii, water as solvent)//B3LYP/6-31+G(d) 
Some of the compounds could not be modelled using the Windows 
Gaussian 09 system owing to computer resource limitations. 
7 Gaussian-4/CPCM(UFF radii, water as solvent)//B3LYP/6-31+G(d) 
Some of the compounds could not be modelled using the Windows 
Gaussian 09 system owing to computer resource limitations. 
a B3LYP/6-311++G(3df,3pd)/CPCM(UFF radii, water as solvent)//B3LYP/6-31+G(d) means that the single-point energy 
calculation at B3LYP/6-311++G(3df,3pd)/CPCM(UFF radii, water as solvent) based on the optimised structure at 
B3LYP/6-31+G(d) in vacuum. 
 In order to simplify the calculations, only the optimised structures in solvent models 
were calculated. The calculated free energy differences between the neutral and deprotonated 
structures (∆G*calculated) of the fifteen HPOs were plotted against their experimental hydroxyl pKa 
values to search for correlations. The r2 values of the regressions were taken to evaluate which 
model chemistry gave the best performance. For deprotonated structures, there are two ways to 
obtain the calculated free energy. One is to calculate a single-point energy for the deprotonated 
form of the optimised neutral structures and the other is to further optimise the structure. The 
different model chemistries explored differ mainly in the nature of the solvent models used 
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(CPCM, IEF-PCM, I-PCM, SCI-PCM or SMD) and the radii employed in the CPCM models (UFF, 
UAHF, UAKS, Bonding, or Pauling). 
 The model chemistry that provided the best results was found to be B3LYP/6-
31+G(d)/CPCM(Pauling radii, water as solvent), with r2 = 0.98 (Figure 3-3). For this method, all 
the neutral and deprotonated forms required optimisation. B3LYP/3-21G (a lower basis set), 
CAM-B3LYP/6-31+G(d) (a modified functional which is suitable for long range calculations) and 
PM6 (a semi-empirical method) with the same solvent model were also tested. However, they 
did not produce superior outcomes with respect to either accuracy or computing time. (Any 
further calculations including, for example, explicit solvent were not performed since the 



























Figure 3-3 Correlation of experimental hydroxyl pKa valuesa against the calculated free energy differences 
(∆G*calculated) for the starting fifteen HPOs using B3LYP/6-31+G(d)/CPCM (Pauling radii, water as solvent).  
a The errors related to the experimental hydroxyl pKa determination for the typical HPOs are estimated to be of the order 
of ± 0.1 (see discussion in Chapter 2). 1 Hartree = 627.5095 kcal mol-1. 
3.2.2 Deprotonation sequence determination 
With the aid of QM static calculations, the assignment of deprotonation sequence can be 
decided by comparing the potential energies of the possible tautomers. If their potential 
energies differ by more than 0.6 kcal mol-1, the tautomer with the lowest potential energy can be 
considered to be the major deprotonated form in solution. (Calculations involving Boltzmann 
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averaging over multiple low energy conformers were not performed since the additional 
computing time required could not be justified.) 
3.2.3 QSPR pKa prediction methods 
The hydroxyl pKa values of the sixty-five HPOs (Table 3-1) were also predicted using ACD/pKa 
DB 12.0 (http://www.acdlabs.com/) and Marvin 5.4.0.1 (http://www.chemaxon.com/). The 
ACD/pKa DB 12.0 method is centred on linear free energy relationships, using the empirical 
relations of Hammett and Taft (Liao and Nicklaus, 2009). The Marvin 5.4.0.1 method is centred 
on quantitative structure-property relationships, associating calculated structural descriptors 
with experimental pKa values (Liao and Nicklaus, 2009). 
3.3 Results 
3.3.1 pKa predictions using ACD and Marvin 
The ACD/pKa DB 12.0 method fails to provide accurate hydroxyl pKa values for any of the sixty-
five HPOs included in this study (Figure 3-4). In particular, values for the 2-amido-, 2-(piperidin-
1-ylmethyl)-, 2-fluoro and 2,6-difluoro-HPO subclasses are poorly predicted. The Marvin 5.4.0.1 
method also fails to provide accurate predictions (Figure 3-5), the poorest being for the 2-
(piperidin-1-ylmethyl)- and 2-fluoro-HPO subclasses. 
 
Figure 3-4 ACD predictions for hydroxyl pKa values. ▲ 2-(piperidin-1-ylmethyl)-HPOs;  2-fluoro-HPOs; ● 2-
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Figure 3-5 Marvin predictions for hydroxyl pKa values. ▲ 2-(piperidin-1-ylmethyl)-HPOs;  2-fluoro-HPOs. 
 
 
3.3.2 Developed pKa prediction model 
As discussed above, B3LYP/6-31+G(d)/CPCM(Pauling radii, water as solvent) generated 
comparatively reliable predictions of hydroxyl pKa values for a series of fifteen HPOs. The pKa 
values for an additional forty-eight HPOs were computed using the same model chemistry to 
develop the final pKa prediction model ─ Predicted pKa = 245.16 ∆G*calculated - 102.95 (r2 = 0.95, 
|M| = 0.20 and |S| = 0.16, Figure 3-6; values in Table 3-1). Unlike the ACD/pKa DB 12.0 and 
Marvin 5.4.0.1 methods, this model provides a good correlation between the predicted and 
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Figure 3-6 Developed pKa prediction model. ▲ YMF11;  CP751. 
 In order to further investigate the predictive power of this model, two novel HPOs, 
CP751 and YMF11, were synthesised by Ma (Chen et al., 2012a). The experimental hydroxyl 
pKa value of CP751 is within the pKa training range while that of YMF11 is outside the pKa 
training range (Figure 3-6). However, the data points for both molecules fell close to the 
regression line, indicating reliable predictions. The absolute deviation between the predicted 
and experimental pKa values for CP751 (10.18, 10.31) is 0.13 and for YMF11 (5.58, 5.15) is 
0.43. 
3.4 Discussion 
With HPOs possessing more than two pKa values, the assignment of pKa values can become 
complicated. This is true in the cases of 2-(piperidin-1-ylmethyl)-HPOs (e.g. CP417) and some 
2-fluoro-HPOs (e.g. YMF6). The deprotonation sequence of CP417 was previously incorrectly 
assigned (Figure 3-7c) and as a result, the hydroxyl pKa value was assigned as 10.51 (Dehkordi 
et al., 2008). However, QM static calculations for the tautomers (Figure 3-8) suggest a different 
deprotonation sequence (Figure 3-7b) and the hydroxyl pKa is assigned as 6.71.  
The fact that the hydroxyl pKa value of 2-(piperidin-1-ylmethyl)-HPOs is less than 7 is 
tentatively attributed to the formation of a strong intramolecular hydrogen bond (Figure 3-9a), by 
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less than 7. The hydrogen bonding depicted in Figure 3-9b has been confirmed by X-ray 
diffraction (Piyamongkol et al., 2010). 
 The pKa assignments for some 2-fluoro-HPOs are not straightforward. If 2-fluoro-HPOs 
have a 1-alkyl group, there is no complexity in the assignments, and such compounds behave 
as typical alkyl HPOs. In contrast, if 2-fluoro-HPOs have a 1-hydrogen group, the assignments 
become complicated owing to the generation of a third pKa value (Figure 3-7d). Based on QM 
static calculations, it is suggested that the NH group deprotonates before the hydroxyl group 
(Figure 3-7d). This deprotonation results in an electronic effect, leading to the oxygen of the 
hydroxyl group attracting the proton more tightly. Thus, the hydroxyl pKa values in this series of 
compounds are higher than in alkyl HPOs. 
 
 
Figure 3-7 (a) Deprotonation sequence of CP20. 
(b) Deprotonation sequence of CP417. 
(c) Deprotonation sequence of CP417. proposed by Dehkordi et al. (2008). 
(d) Deprotonation sequence of YMF6. 
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Figure 3-8 CP417 tautomersa.  





Figure 3-9 (a) intramolecular hydrogen bond for CP417; (b) intramolecular hydrogen bonds for CP511. 
This study demonstrates that there are two broad classes of outliers for both the ACD/pKa 
DB 12.0 and Marvin 5.4.0.1 programs (Figures 3-4 and 3-5). One is centred on HPOs 
possessing intramolecular hydrogen bonding with the 3-oxygen atom, such as CP417, a 2-
(piperidin-1-ylmethyl)-HPO. The other one is centred on HPOs possessing strong electron 
withdrawing functional groups, such as YMF6, a 2-fluoro-HPO. It is clear that intramolecular 
hydrogen bonding and electronic effects are the two main factors which the two commercial 
prediction programs cannot successfully accommodate unlike QM static calculations based on 
the approximation of Schrödinger equations. 
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Chapter 4 Prediction of HPO Hydroxyl pKa Values Using 
Quantum Mechanical Molecular Dynamic Simulations with 
Explicit Solvent 
4.1 Introduction 
Predictions of three HPOs’ hydroxyl pKa values were made using quantum mechanical 
molecular dynamic (QM MD) simulations involving explicit solvent and the results obtained were 
compared with those determined by experiment and obtained using the other theoretical 
methods described in Chapter 3. In addition to predicting the pKa values, the QM MD 
simulations provide valuable additional insights into the atomistic details of the proton transfer 
mechanism and the hydration structures and dynamics at all stages of the reaction. The 
hydration properties were further examined by means of radial distribution functions, correlated 
with the order of their experimentally determined pKa values. The main results of this chapter 
are published in Chen et al. (2012c). 
4.2 Methods 
4.2.1 Coordination constrained Car-Parrinello Molecular Dynamics simulations 
Constrained Car-Parrinello molecular dynamics (CP-MD) simulations with the CP-MD software 
(http://www.cpmd.org/) were carried out for three different HPOs (CP20, CP60, and CP751, 
Figure 4-1) surrounded by 61 H2O molecules in a periodically repeating cubic unit cell of size 
12.4 Å x 12.4 Å x 12.4 Å.  The Kohn-Sham equations were solved using the PBE (Perdew et al., 
1996) exchange-correlation functional in a plane wave basis set truncated at 25 Ry (340 eV), in 
conjunction with ultrasoft pseudopotentials (Vanderbilt, 1990).  The coupled nuclear and 
fictitious electronic equations of motion were solved using a timestep of 6 a.u. (0.145 fs), setting 
the fictitious orbital mass to 800 a.u. (0.439 a.m.u.), and replacing all hydrogens with deuterium.  
A Nosé-Hoover chain thermostat (Hoover, 1985; Nose, 1984) was applied to maintain the 
nuclear temperature at 350 K. A slightly raised temperature is necessary in CP-MD simulations 
with this type of exchange-correlation functional to reproduce structural and dynamical 
experimental data for liquid water at room temperature (Fernandez-Serra and Artacho, 2004; 
Schwegler et al., 2004; Sit and Marzari, 2005). 









Figure 4-1 Simulated HPO structures. CP20: R1 = R2 = CH3 and R5 = R6 = H; CP60: R1 = CH3 and R2 = R5 = R6 = H; 
CP751: R1 = R2 = R5 = CH3 and R6 = H. 
The number of protons coordinated to the 3-hydroxyl oxygen of HPOs was calculated 
using the formula: 
n = i ci rr 1)](exp[
1
    (1) 
with a cutoff radius of rc = 2.46 a.u. (1.30 Å) and κ = 5.29 a.u.-1 (2.80 Å-1), ri being the distance 
between the 3-hydroxyl oxygen and the i th proton. For each fixed proton coordination number n, 
a trajectory of at least 1.5 ps was calculated and the time-averaged constraint force < f > was 
determined. Each simulation was run until the running average of the constraint force reached a 
relative standard deviation of less than 2% during the last 0.7 ps.  
The free energy difference between the initial equilibrium state (with the intact 3-
hydroxyl group) at the coordination number of n0, and the final state (at the top of the reaction 
barrier) at the coordination number of nf, ∆A, was obtained by thermodynamic integration: 
∆A = A(nf) – A(n0) =  fnn dnnf0 )('    (2) 
where <f '(n)> is the potential of mean force, the metrically corrected time-averaged constraint 
force (Sprik and Ciccotti, 1998) < f >. The free energy difference was converted to a molar 
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is the probability of finding a proton within the radius Rc, k is the Boltzmann constant, T is the 
absolute temperature, C0 is the standard concentration (1 mol dm-3), and V is the volume of the 
simulation cell. Rc, the critical distance at which the 3-hydroxyl oxygen (O3) share its proton with 
H2O equally, was estimated to be 1.3 Å based on the O3H radial distribution functions, and Rf 
was taken as the O3H distance at the final coordination number nf, at which O3 loses its proton 
completely. 
4.3 Results 
The potential of mean force and the corresponding free energy profiles of CP-MD simulations at 
different proton coordination numbers (n) for the three HPOs are presented in Figure 4-2. The 
simulations were started at thermal equilibrium with the fully intact 3-hydroxyl group, 
corresponding to n ~ 0.96, at which the mean force is practically zero. When the proton 
coordination number is decreased, the O3H bond is stretched, resulting in a sharp rise in the 
constraint force until it reaches a maximum at n ~ 0.93. When n is decreased further, the mean 
force reduces towards zero at which the system approaches the transition state for the proton 
transfer prior to becoming negative when the system enters the product potential. Snapshots for 
the different stages of the proton transfer reaction are illustrated in Figure 4-3. Simulations 
carried out from n ~ 0.96 to n ~ 0.3 are sufficient to predict the pKa values because only the 
region up to the transition state is relevant for the corresponding free energy barrier. The force 
curves (Figure 4-2a) show that the highest peak belongs to CP751, followed by CP20 and CP60, 
the lowest, and this order is reflected in the corresponding free energy profiles (Figure 4-2b). 
CP751 possesses the largest free energy barrier (∆A = 36.3 kJ mol-1), followed by CP20 (∆A = 
32.1 kJ mol-1) and CP60 (∆A = 27.5 kJ mol-1). These free energies were converted to the pKa 
values as 10.73 (CP751), 9.36 (CP20), and 9.00 (CP60) (Table 4-1).  
The pKa predictions from the CP-MD simulations are compared to their experimental 
measurements (Chen et al., 2012a; Kong, 2008) and those obtained via the other theoretical 
methods described in Chapter 3 (Table 4-1). The ACD/pKa DB 12.0 method yields good 
predictions for CP751 and CP20 but a significant error for CP60, with the difference between 
the measured and predicted pKa values being almost 1 log unit. The Marvin 5.4.0.1 method 
yields very poor predictions and overestimates the pKa values for all three HPOs by about 1 log 
unit. The direct method yields pKa values that follow the correct trend but with the absolute 
predicted values overestimated for all three HPOs by greater than 6 log units. The proton 
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exchange scheme corrects the absolute predicted values derived from the direct method – 
reducing the average absolute error from 6.25 to 0.99, but still yielding pKa values of insufficient 
accuracy. The CP-MD method yields very good predictions with respect to trend and average 
absolute error (0.34) for all three HPOs. Compared to the other methods, QM static calculations 
with a regression model developed in Chapter 3 yield the best results. 
 
Proton coordination number 
 
Figure 4-2 Mean force (a) and the corresponding free energy (b) versus proton coordination number for 
the three HPOsa. 









CP20: R1 = R2 = CH3 and R5 = R6 = H 
CP60: R1 = CH3 and R2 = R5 = R6 = H 
CP751: R1 = R2 = R5 = CH3 and R6 = H 
 





Figure 4-3 Snapshots from the simulation of hydrated CP20 illustrating the deprotonation process induced 
by the coordination constraint.  
(a) n = 0.97: the proton is covalently bonded to the O3 atom with a hydrogen bond to a nearby H2O molecule. (b) n = 
0.71: the proton is shared between the O3 atom and the nearby H2O molecule (c) n = 0.31: a chain of three H2O 
molecules forms a bridge mediating a proton transfer chain reaction between the O3 and O4 atoms (d) n = 0.01: the O3 
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Table 4-1 pKa prediction results using different methods. 
 CP60 CP20 CP751 Average Absolute Error 
Measured value 8.79a 9.76a 10.32b N/A 
CP-MD 9.00 9.36 10.73 0.34 
ACD/pKa DB 12.0 9.59 9.90 10.03 0.41 
Marvin 5.4.0.1 10.79 10.72 10.71 1.12 
The direct method using 
B3LYP/6-31+G(d)/CPCM 14.32 15.90 17.36 6.25 
Proton exchange scheme using 
B3LYP/6-31+G(d)/CPCM 9.07 10.65 12.11 0.99 
QM static calculations 
with a regression model 8.81 9.76 10.18 0.06 
Experimental pKa values taken from a Kong (2008); b Chen et al. (2012a) or Chapter 2. 
4.4 Discussion 
Although the CP-MD method yields only the second best predictions with respect to average 
absolute error among all the methods described in this study, it does provide valuable additional 
insights into the atomistic details of the proton transfer mechanism and the hydration structures 
and dynamics at all stages of the reaction. Moreover, the CP-MD method is an ab initio MD 
method, meaning that no experimental data are required and this can be superior to the QM 
static calculations with a regression model for predictions involving novel compounds with few 
existing data. 
The distances of the transferring hydrogen to the donor oxygen (O3 of HPO) and the 
acceptor oxygen (OA of H2O) versus O3 proton coordination number (n) for all three HPOs were 
analysed (Figure 4-4).  Near thermal equilibrium (n ~ 0.97), the O3H bond length is observed to 
be at its equilibrium value of about 0.99 Å for all three HPOs, while the H…OA hydrogen bond 
length exhibits significant variation. CP60 is observed to have the shortest average hydrogen 
bond length of around 1.7 Å, in an agreement with the fact that it possesses the lowest pKa 
value. CP751 is observed to have the longest average hydrogen bond length of about 2.1 Å, in 
agreement with the fact that it possesses the highest pKa value. CP20 is observed to lie 
between CP60 and CP751 with respect to the average hydrogen bond length and pKa value. 
These differences in hydrogen bond length among the three HPOs may be explained by the 
differences in the water hydrogen bonding networks surrounding their O3 atoms – which arise 
because of their diverse patterns of methyl substitution which lead to differing numbers of water 
molecules within a radius of about 3 Å from O3 (Figures 4-5b and 4-6a). Interestingly, for all 
three HPOs, the crossover point at which the transferring H is midway between O3 and OA 
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coincides at n = 0.72 where the OH distance is around 1.25 Å. After the transition state, the 
curves for the three HPOs diverge slightly, indicating that CP60 forms the tightest HOA bond, 
followed by CP20 and CP751.   
Radial distribution functions (RDFs) between the O3 and water oxygens were calculated 
to search for a correlation between the pKa value of HPO and its hydration properties. The O3–
O RDFs for the three HPOs at n = 0.97 are presented in Figure 4-5. The first RDF peak of CP60 
is much higher and the separation between the first and second peaks is much more 
pronounced than for the other two HPOs, indicating a much stronger solute – solvent interaction 
compatible with its lowest pKa value. Although the first peak for CP751 is higher than that for 
CP20, the number of water molecules within a radius of about 4 Å from its O3 is significantly 
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Figure 4-4 Mean OH distances between the transferring H, and the donor (O3 of HPO) and acceptor (OA 
of H2O) oxygen versus O3 proton coordination number for the three HPOsa.  









Figure 4-5 O3–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated HPOsa 
at a mean proton coordination number of 0.97.  














Figure 4-6 Schematic diagram illustrating the 3 Å and 5 Å HPO coordination radii with origin (a) at O3; (b) at O4. 
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In addition to providing atomistic level insights into the hydration and proton transfer 
properties of the different HPOs, the simulations also offer the possibility to characterise the 
final product state after proton transfer. Using the methodology applied in this work, it would be 
possible to determine the pKa values of the carbonyl oxygen O4, which is fully protonated at the 
end of the simulation (n  0). However, a quantitative analysis of this was not attempted here. 
Instead, attempts were made to rationalise the experimentally determined pKa values of 3.66, 
3.38, and 3.28 (Kong, 2008) for CP20, CP60 and CP751, respectively, on the grounds of their 
hydration structures. The O4–O RDFs in Figure 4-7a indicate that CP751 forms stronger 
hydrogen bonds at O4, the first peak appearing at a shorter distance compared to the other two 
HPOs, which may explain the slightly lower pKa value of CP751. The RDF for CP20 exhibits a 
much more pronounced dip between the first and second peaks which means that the first and 
second hydration shells are well separated. Thus, the integrated H2O coordination number 
around O4 for CP20 is significantly lower than that for the other two HPOs up to a distance of 
about 4.5 Å (Figures 4-7b and 4-6b), and this may correlate with the increased pKa value of 
CP20. Comparison of Figures 4-5b and 4-7b indicates that the differences in the H2O 
coordination number around O4 are much smaller than those around O3, explaining the smaller 
differences in the pKa values of the O4H group. 
 In summary, the CP-MD method provides predicted hydroxyl pKa values comparable in 
accuracy with those derived through the QM static method plus experimental fitting described in 
Chapter 3, and reveals that the proton transfer for all three HPOs takes place along a chain of 
three H2O molecules although direct hydrogen bonds are observed to form transiently. The 
distribution of methyl substitution around the aromatic HPO ring seems to affect the ambient 
water networking significantly and can partially account for the pKa value differences. 
 





Figure 4-7 O4–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated HPOsa 
at a mean proton coordination number of 0.01, complete proton transfer from O3 to O4. 
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Chapter 5 Prediction of HPO log K1 Values 
5.1 Introduction 
log K1 is another important physicochemical property of iron (Fe3+) chelators, closely related to 
the coordinating functional group pKa values, and one of the variables influencing pFe3+. The 
prediction of this was made using QM static calculations, employing a methodology analogous 
to that described in Chapter 3. Prior to the prediction, the experimental HPO log K1 values were 
verified via their correlation with the corresponding sum of the coordinating functional group 
experimental pKa values. The prediction methodology reported here is the first to be provided 
for predicting the absolute log K1 values of iron-chelating agents in the absence of pKa values. 
The main results from this are published in Chen et al. (2012b). 
5.2 Methods 
5.2.1 Prediction of HPO log K1 values using QM static calculations 
In order to simplify calculations and to decrease computing time, only two types of optimised 
structures, namely deprotonated ligand (L-) and iron (Fe3+) complex ([Fe3+L1]2+), in solvent 
models were computed (as analogous to the related studies detailed in Chapter 3 and in Chen 
et al. (2012a)). The calculated free energy differences (∆G*calculated) between the two optimised 
structures of the eleven training set HPOs (Table 5-1) were plotted against their experimentally 
determined log K1 values in order to assess the correlation. The correlation coefficient (r) for the 
regression between predicted and experimental values and their mean and standard deviation 
of absolute deviations (|M| and |S|) were used to investigate the performance of various model 
chemistries. The different model chemistries at B3LYP/6-31+G(d) level explored here vary very 
significantly according to the solvent model employed (IEF-PCM, CPCM, SMD, I-PCM or SCI-
PCM) (Foresman and Frisch, 1996) and the radii employed in the CPCM models (Bonding, 
Pauling, UFF, UAHF, or UAKS). For [Fe3+L1]2+, there are two constructed starting structures: 
one, without explicit water molecules (Figure 5-1a) and the other, with four explicit water 
molecules octahedrally distributed around the Fe3+ (Figure 5-1b). All the optimised geometries 
(directly optimised in solvent models; force constants calculated at each step; without symmetry 
constraints; the spin multiplicity = 6 for [Fe3+L1]2+) were calculated using Gaussian 09 (Frisch et 
al., 2009), and the conformers generated were verified as corresponding to local minima on 
their potential energy surfaces (with no imaginary frequencies existing in the output files). Prior 
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to running the Gaussian 09 optimisation, conformational searches at AM1 level were performed 
using HyperChem Release 8 (http://www.hyper.com/) to obtain the global (or nearly global) 
minimum energy conformer for all the molecules studied here. (Any further calculations 
including, for example, Boltzmann averaging over multiple low energy conformers were not 
performed since the additional computing time required could not be justified.) 
 The model chemistry which produced the best result was found to be B3LYP/6-
31+G(d)/CPCM(Bondi radii, water as solvent) with [Fe3+L1]2+ structures modelled in the absence 
of explicit water molecules (r2 = 0.90, |M| = 0.16 and |S| = 0.09; (Figure 5-2)). Adopting the 
same solvent model, B3LYP*/6-31+G(d) (which has 10%, 15%, 25%, 30%, 35%, or 40% 
Hartree-Fock exchange compared to 20% for B3LYP), CAM-B3LYP/6-31+G(d) (a modified 
functional which is suitable for long range calculations), B3LYP/3-21G (a lower basis set), PM6 
(a semi-empirical method), were also tested. However, no superior outcomes were detected 




Figure 5-1 [Fe3+L1]2+ Structures: (a) with no explicit water molecules; (b) with four explicit water molecules 
octahedrally distributed around Fe3+. 
 



















Figure 5-2 Correlation of experimental log K1 valuesa against the calculated free energy differences 
(∆G*calculated) for the eleven training set HPOs using B3LYP/6-31+G(d)/CPCM(Bondi radii, water as 
solvent).  
a The errors related to the experimental log K1 determination for the typical HPOs are estimated to be of the order of ± 
0.15 (see discussion in Chapter 2). 1 Hartree = 627.5095 kcal mol-1 
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Table 5-1 Structures, predicted (experimental) log K1 values and calculated free energy differences 









HPOs R1 R2 R5 R6 
CP20a −CH3 −CH3 −H −H 
CP21a −C2H5 −CH3 −H −H 
CP23a −CH(CH3)2 −CH3 −H −H 
CP60a −CH3 −H −H −H 
CP61a −C2H5 −H −H −H 
CP68a −CH3 −CH3 −H −CH3 
CP69a −CH3 −H −H −CH3 
CP90a −H −H −H −H 
CP93a −CH3 −C2H5 −H −H 
CP94a −C2H5 −C2H5 −H −H 
CP99a −H −C2H5 −H −H 
CP360 −CH3 −CH2OH −H −CH3 
CP369 −C2H5 −CH2OH −H −CH3 
CP374 −CH3 −CHC2H5OH −H −CH3 
CP502 −CH3 −CONHCH3 −H −CH3 
CP509 −H −CON(CH3)2 −H −CH3 
CP513 −CH3 −CONHC2H5 −H −CH3 
CP514 −C2H5 −CONHCH3 −H −CH3 
YMF5 −H −H −F −H 
YMF7 −CH3 −F −H −H 
YMF8 −C2H5 −F −H −H 
YMF14 −CH3 −F −CH3 −H 
YMF15 −CH3 −H −F −H 
YMF16 −C2H5 −H −F −H 
YMF17 −CH3 −CH3 −F −H 
YMF21 −H −H −F −CH3 
YMF22 −H −CH3 −F −H 
YMF24 −C3H7 −F −H −H 
YMF25 −C3H7 −H −F −H 
YMF26 −CH(CH3)2 −H −F −H 
YMF33 −C4H9 −F −H −H 
CP102 −C2H4OH −C2H5 −H −H 
CP110 −C2H4COOH −C2H5 −H −H 
CP359 −C2H5 −CH2OH −H −H 
CP364 −CH3 −CH2OH −H −H 
CP365 −C2H5 −CHCH3OH −H −H 
CP366 −C3H6OH −CH2OH −H −H 
CP372 −C3H6OH −CHCH3OH −H −H 
CP511 −H −CONHCH3 −H −CH3 
CP545 −H −CONHC2H4OH −H −H 
CP510 −CH3 −H −H −CONHCH3 
CP28 −H −CH3 −H −H 
CP38 −C2H4COOH −CH3 −H −H 
CP40 −C2H4OH −CH3 −H −H 
CP111 −C3H6COOH −C2H5 −H −H 
CP352 −C2H4OH −CH(C6H5)OH −H −CH3 
CP362 −CH3 −CH2OCH3 −H −CH3 
CP363 −CH3 −CH(CH3)OCH3 −H −CH3 
CP414 −CH3 −CH2(NC5H10) −H −CH3 
CP417 −CH3 −CH2(NC5H10) −H −CH2OH 
CP751 −CH3 −CH3 −CH3 −H 
YMF3 −H −F −F −F 
YMF4 −H −F −H −F 
CP70 −H −H −H −CH3 
CP370 −C2H5 −CH2OCH3 −H −CH3 
CP375 −CH3 −CHC2H5OCH3 −H −CH3 
CP616 −H −CH3 −CH3 −H 
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Table 5-1 continued 
HPOs ∆G*calculated (G*calculated for [Fe3+L1]2+, L-) (Hartree)g log K1 
CP20a -1263.2292 (-1740.0518, -476.8226) 14.79 (15.09)b 
CP21a -1263.2305 (-1779.3418, -516.1113) 14.98 (14.82)b  
CP23a -1263.2309 (-1818.6296, -555.3987) 15.04 (15.00)b  
CP60a -1263.2209 (-1700.7550, -437.5340) 13.64 (13.57)b  
CP61a -1263.2227 (-1740.0471, -476.8244) 13.88 (14.11)b  
CP68a -1263.2333 (-1779.3443, -516.1110) 15.37 (15.22)b  
CP69a -1263.2245 (-1740.0498, -476.8253) 14.14 (13.86)b  
CP90a -1263.2199 (-1661.4703, -398.2503) 13.50 (13.73)b  
CP93a -1263.2303 (-1779.3381, -516.1078) 14.96 (14.77)b  
CP94a -1263.2307 (-1818.6283, -555.3975) 15.01 (15.12)b  
CP99a -1263.2282 (-1740.0596, -476.8314) 14.65 (14.82)b  
CP360 -1263.2241 (-1854.5518, -591.3277) 14.09 (14.39)c 
CP369 -1263.2242 (-1893.8405, -630.6162) 14.10 (14.37)c  
CP374 -1263.2212 (-1933.1295, -669.9084) 13.67 (14.41)c  
CP502 -1263.2174 (-1948.0243, -684.8069) 13.14 (13.41)d 
CP509 -1263.2169 (-1948.0272, -684.8103) 13.08 (12.85)d  
CP513 -1263.2164 (-1987.3136, -724.0972) 13.00 (12.84)d  
CP514 -1263.2183 (-1987.3120, -724.0937) 13.28 (12.96)d  
YMF5 -1263.2103 (-1760.7086, -497.4982) 12.15 (11.57)e 
YMF7 -1263.2141 (-1799.9948, -536.7807) 12.69 (11.95)e  
YMF8 -1263.2146 (-1839.2858, -576.0712) 12.75 (11.98)e 
YMF14 -1263.2178 (-1839.2906, -576.0728) 13.20 (13.14)e 
YMF15 -1263.2117 (-1799.9937, -536.7820) 12.35 (12.14)e 
YMF16 -1263.2129 (-1839.2857, -576.0728) 12.51 (12.69)e 
YMF17 -1263.2196 (-1839.2903, -576.0706) 13.46 (13.61)e 
YMF21 -1263.2131 (-1800.0077, -536.7946) 12.54 (12.50)e 
YMF22 -1263.2170 (-1800.0099, -536.7929) 13.09 (13.21)e 
YMF24 -1263.2144 (-1878.5745, -615.3601) 12.73 (12.20)e 
YMF25 -1263.2124 (-1878.5741, -615.3617) 12.44 (11.88)e 
YMF26 -1263.2133 (-1878.5751, -615.3618) 12.57 (11.76)e 
YMF33 -1263.2147 (-1917.8633, -654.6486) 12.77 (12.37)e 
CP102 -1263.2278 (-1893.8415, -630.6136) 14.61 (14.69)f 
CP110 -1263.2271 (-2007.2015, -743.9744) 14.50 (14.78)f 
CP359 -1263.2226 (-1854.5508, -591.3281) 13.88 (14.26)f 
CP364 -1263.2206 (-1815.2591, -552.0386) 13.59 (14.28)f 
CP365 -1263.2197 (-1893.8404, -630.6207) 13.47 (14.15)f 
CP366 -1263.2203 (-1969.0530, -705.8327) 13.55 (13.82)f 
CP372 -1263.2195 (-2008.3458, -745.1263) 13.43 (14.29)f 
CP511 -1263.2063 (-1908.7534, -645.5471) 11.59 (12.03)f 
CP545 -1263.2005 (-1983.9593, -720.7588) 10.77 (11.32)f 
CP510 -1263.2172 (-1908.7311, -645.5139) 13.12 (12.20)f 
CP28 -1263.2268 (-1700.7715, -437.5446) 14.46 (14.49)f 
CP38 -1263.2265 (-1967.9156, -704.6891) 14.42 (14.62)f 
CP40 -1263.2280 (-1854.5560, -591.3280) 14.63 (14.61)f 
CP111 -1263.2276 (-2046.4899, -783.2623) 14.57 (14.58)f 
CP352 -1263.2162 (-2200.0370, -936.8208) 12.97 (13.02)f 
CP362 -1263.2249 (-1893.8275, -630.6026) 14.19 (14.45)f 
CP363 -1263.2280 (-1933.1183, -669.8903) 14.64 (15.00)f 
CP414 -1263.2056 (-2030.3502, -767.1446) 11.49 (11.59)f 
CP417 -1263.2013 (-2105.5593, -842.3581) 10.88 (10.98)f 
CP751 -1263.2338 (-1779.3475, -516.1137) 15.44 (15.51)f 
YMF3 -1263.2358 (-1958.7859, -695.5501) 15.72 (15.06)f 
YMF4 -1263.2455 (-1859.5496, -596.3041) 17.08 (16.52)f 
CP70 -1263.2226 (-1700.7691, -437.5465) 13.87 (14.09)f 
CP370 -1263.2257 (-1933.1174, -669.8917) 14.31 (14.29)f 
CP375 -1263.2279 (-1972.4049, -709.1770) 14.62 (14.50)f 
CP616 -1263.2309 (-1740.0669, -476.8360) 15.04 (15.17)f 
 
a The first eleven HPOs were used to test different model chemistries; experimental log K1 values taken from b Kong 
(2008); c Liu et al. (1999); d Piyamongkol et al. (2010); e Ma et al. (2012); f this study obtained from Chapter 2; g 
∆G*calculated: the calculated free energy differences between [Fe3+L1]2+ and L- using B3LYP/6-31+G(d)/CPCM(Bondi radii, 
water as solvent) (G*calculated: the calculated free energy); 1 Hartree = 627.5095 kcal mol-1. 
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5.3 Results 
5.3.1 Validation of experimental log K1 values 
In order to obtain a large group of HPOs with reliable experimentally determined log K1 values, 
a plot of experimental log K1 value versus the corresponding sum of experimental pKa values 
(hydroxyl pKa values plus carbonyl pKa values) was utilised. From the existing literature (Kong, 
2008; Liu et al., 1999; Ma et al., 2012; Piyamongkol et al., 2010; Rai et al., 1998), forty-one 
HPOs were selected for initial analysis. Thirty one of these HPOs were found to give the 
expected linear correlation (Hider and Hall, 1991) between their log K1 values and the 
corresponding sum of their pKa values, r2 = 0.95 (Figure 5-3). However, nine HPOs were found 
to have significantly higher log K1 values than predicted from the linear relationship, while one 
HPO was found to possess a significantly lower log K1 value (Figure 5-3). After determining the 
affinity constants using a 10 : 1 molar ratio of L : Fe3+ for the ten HPO outliers (Table 5-1 or 
Table 5-2 including former values) and sixteen previously uncharacterised HPOs (Table 5-1), 
four of which were specifically synthesised for this study by Ma (Chen et al., 2012b), fifty-seven 
HPOs in total were found to give the expected linear relationship between their experimental log 
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Figure 5-3 Correlation of experimental log K1 values against the sum of experimental pKa values for forty-
one HPOsa, extracted from the existing literatureb. 
 CP102, CP110, CP359, CP364, CP365, CP366, CP372, CP511, CP545; ▲CP510;  
a the structures of the forty-one HPOs are presented in the first forty-one rows of Table 5-1. b(Kong, 2008; Liu et al., 
1999; Ma et al., 2012; Piyamongkol et al., 2010; Rai et al., 1998) using a 3.5 : 1 molar ratio of L : Fe3+. 
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Figure 5-4 Correlation of experimental log K1 values against the sum of experimental pKa values for fifty-
seven HPOsa. 
a The structures of the fifty-seven HPOs are presented in Table 5-1. Ten outliers in Figure 5-3 were re-determined using 
a 10 : 1 molar ratio of L : Fe3+. 
 




a The structures of these HPOs are given in Table 5-1; experimental log K1 values taken from b Rai et al. (1998); c Liu et 
al. (1999); d Piyamongkol et al. (2010). 
 
5.3.2 Developed log K1 prediction model 
As discussed above, B3LYP/6-31+G(d)/CPCM(Bondi radii, water as solvent), with [Fe3+L1]2+ 
structures being in the absence of explicit water molecules, was found to produce a relatively 
reliable prediction of log K1 values for an initial series of eleven HPOs. The log K1 values for an 
additional forty-two HPOs were calculated using the same model chemistry to develop the final 
log K1 prediction model ─ Predicted log K1 = -140.18 ∆G*calculated - 177063.32 (r2 = 0.90, |M| = 
0.32 and |S| = 0.25, Figure 5-5; values in Table 5-1). In an attempt to further examine the 
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synthesised by Ma (Chen et al., 2012b). The predicted log K1 values for all four compounds 
were observed to be close to their experimental values, indicating reliable predictions (Figure 
5-5). The absolute deviations between the predicted and experimental values are 0.22 for CP70 
(13.87 vs. 14.09), 0.02 for CP370 (14.31 vs. 14.29), 0.12 for CP375 (14.62 vs. 14.50), and 0.13 
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Figure 5-5 Developed log K1 prediction model. 
 CP70, CP370, CP375 and CP616; ▲CP510 with the largest absolute deviation (0.92); Omission of the CP510 data 
point changes only the third decimal place in r2 and results in an insignificant change of the fitted line, and thus an 
insignificant change of the predicted log K1 values. 
 
5.4 Discussion 
The methodology developed for prediction of HPO log K1 values is impressive (with the 
observed and predicted values strongly correlated, with r2 of 0.90; Figure 5-5). In comparison, 
the errors associated with the experimental determination of log K1 for the typical HPOs are 
estimated to be of the order of ± 0.15 (see the discussion in Chapter 2). However, for some 
HPOs which are associated with experimentally difficult log K1 determinations, the error can 
exceed 1.0 (Table 5-2). The plot of experimental log K1 versus the corresponding sum of 
experimental pKa values (Figure 5-4) was utilised to evaluate this experimental error. The 
utilisation of the sum of experimental pKa values rather than the single carbonyl or hydroxyl 
experimental pKa value was adopted because both of the pKa values are associated with 
functional groups which coordinate Fe3+.  
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 The ten HPO outliers in Figure 5-3 can be categorised into four main subclasses, 
namely 1-hydrogen-(2 or 6)-amido-, 2-hydroxymethyl-, 1-hydroxy(ethyl or propyl)- and 1-
carboxyethyl-HPOs. All these HPOs possess hydrogen bond donor and/or acceptor groups for 
the aromatic ring substituents and this may result in a disturbance of the first layer of solvation 
molecules surrounding each iron(Fe3+) complex. This, in turn, will influence the magnitudes of 
their stability constants; for instance, with CP511, which has strong intramolecular hydrogen 
bonding (Piyamongkol et al., 2010), there is an appreciable decrease in log K1 values (Figure 
5-6) when increased molar ratios of L : Fe3+ are employed in the titration. This effect is probably 
associated with the partial formation of a μ-oxo bridge species (Fe3+−O−Fe3+L-1) at relatively 
high Fe3+ molar concentrations, thus disturbing the UV/Vis spectra. For this reason, the 10 : 1 
molar ratio of L : Fe3+ was adopted to minimise the formation of μ-oxo bridges during the 























Figure 5-6 Experimental log K1 versus molar ratio of L : M for CP511. 
 
 A knowledge of pKa values can be neglected using the developed prediction 
methodology for HPO log K1 values and this is particularly useful to predict HPOs possessing at 
least three pKa values. For the experimental log K1 determination of HPOs with more than two 
pKa values, special attention is required to identify which two pKa values correspond to the iron-
coordinating oxygen atoms. If the two pKa values are incorrectly assigned, there will be an 
appreciable error in the associated experimental log K1 value.  
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 In summary, the methodology developed in this study is the first QM approach to predict 
the absolute log K1 value of iron-chelating agents in the absence of pKa values. The plot of 
experimental log K1 values versus the corresponding sum of experimental pKa values (of 
coordinating atoms) has proved to be extremely useful in order to investigate the accuracy of 
experimentally determined log K1 values. The stability constants for HPOs with substituents 
possessing hydrogen bonding donors and/or acceptors should be determined using a 10 : 1 
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Chapter 6 Prediction of HPO Hydration Property Using 
Classical Molecular Dynamic Simulations 
6.1 Introduction 
Given, as noted earlier, that HPOs represent putative therapeutic agents for the treatment of 
neurodegenerative diseases, it is of particular interest to determine their likely blood-brain 
barrier permeability. In the work reported here, the aim was to develop a suitable in silico 
method to allow modelling of the HPO blood-brain barrier permeation and correlation of the 
predicted values with the experimental permeability values (Habgood et al., 1999). Through lack 
of research time, however, it only proved possible to develop the necessary force fields for use 
in these simulations and then to test these in simulation of the HPO behaviour in aqueous 
solution. In the future, the developed force fields could be used in simulations including 
membranes to calculate theoretical blood-brain barrier permeability values for the modelled 
HPOs. 
6.2 Methods 
6.2.1 Extension of CHARMM General Force Field for HPOs 
The extension of the CHARMM (http://www.charmm.org/) General Force Field (CGenFF) 
specific for three HPOs (CP20, CP25 and CP94) was made following the procedures given by 
Vanommeslaeghe et al. (2010). Initial estimates of the specific parameters for HPOs with 
penalty scores indicating their reliability, compared with the structures in CGenFF 2b7 version 
database, were automatically generated using the utilities provided at 
https://www.paramchem.org/index.php. Unfortunately, the HPO structures proved significantly 
different from those in the database (as judged from their penalty scores) and the estimated 
parameters required optimisation, following the procedure shown in Figure 6-1. In the work 
reported here, no novel atom types were incorporated and thus, the optimisation of Lennard-
Jones parameters, accounting for van der Waals interactions, was not required. The 
optimisation of bond, angle and dihedral parameters was carried out for all geometries except 
those covered in the existing CHARMM database. The quantum mechanical reference data 
were generated using Gaussian 03 (Frisch et al., 2004). 









CP20, R1 = R2 = CH3 and R5 = R6 = H 
CP25, R1 = C6H13, R2 = CH3 and R5 = R6 = H 
CP94, R1 = R2 = C2H5 and R5 = R6 = H 
 
 
Figure 6-1 Parameterisation procedure (Vanommeslaeghe et al., 2010).  
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6.2.2 Simulations of HPOs with explicit water molecules using LAMMPS 
Once the three novel HPO CHARMM force fields were optimised, they were tested in MD 
simulations in which each HPO was surrounded by 2,700 H2O molecules in a periodically 
repeating cubic unit cell of size 46 Å x 46 Å x 46 Å using LAMMPS (http://lammps.sandia.gov/). 
The MD simulations were run for three successive 1 ns periods, using NPT conditions (with 
pressure = 1 atm, temperature = 300 K). The HPO hydration properties were analysed using 
radial distribution functions (RDFs). 
6.3 Results 
6.3.1 CHARMM force fields specific for three HPOs 
The CHARMM force field parameters developed for three HPOs and their validation results are 
presented in Tables 6-1 – 6-18 and Figures 6-1 – 6-5. The equilibrium bond lengths, angles, 
dihedrals and improper dihedrals calculated by QM and CHARMM molecular mechanics (MM) 
are presented in Tables 6-1 (CP20), 6-7 (CP25) and 6-13 (CP94). The differences of the bond 
lengths between QM and MM for all three HPOs are within ± 0.03 Å, while those of angles are 
generally within ± 3o, both of these internal coordinate sets thus reaching the acceptance criteria 
specified by Vanommeslaeghe et al. (2010). The HPO-water interaction models for all three 
HPOs are illustrated in Figure 6-2 (interacting atoms: O3, O4, H5 and H6) and the optimised 
interaction energies and distances as a result of charge adjustment (Tables 6-5 for CP20, 6-11 
for CP25 and 6-17 for CP94) are presented in Tables 6-2 (CP20), 6-8 (CP25) and 6-14 (CP94). 
The differences of interaction energies between QM and MM for all three HPOs are within ± 0.2 
kcal mol-1 and the interaction distances of MM are generally 0.2 Å shorter than QM, both the 
interaction energies and distances thus reaching the acceptance criteria specified by 
Vanommeslaeghe et al. (2010). The dipole moments calculated by QM and MM for the three 
HPOs are presented in Tables 6-3 (CP20), 6-9 (CP25) and 6-15 (CP94). The dipole moments 
calculated by MM are generally close to those calculated by QM in this study although it is 
expected  that the MM dipole moment should overestimate the magnitude of the QM one by 20 
to 50% for polar, neutral molecules (Vanommeslaeghe et al., 2010). The vibrational spectra 
calculated by QM and MM as a result of force constants adjustment (Tables 6-6 for CP20, 6-12 
for CP25 and 6-18 for CP94) for the three HPOs are presented in Tables 6-4 (CP20), 6-10 
(CP25) and 6-16 (CP94). The mean of absolute relative deviations between QM and MM 
vibrational frequencies for all three HPOs is within 5%, indicating a good agreement between 
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QM and MM calculations. The potential energy surfaces (PESs) of dihedrals and improper 
dihedrals calculated by QM and MM for the three HPOs are presented in Figures 6-3 (CP20), 6-
4 (CP25) and 6-5 (CP94). The shape of PESs calculated by MM is generally in a good 
agreement with that calculated through QM. Some of MM PESs have large deviations (greater 
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Table 6-1 CHARMM molecular mechanics (MM) equilibrium geometry of CP20, compared to 
QM MP2/6-31G(d) level. 
Coordinate MP2 MM Difference Coordinate MP2 MM Difference
Bond lengths(Å)    Dihedrals(o)    
C1-C2 1.372 1.372 0.001 C6-C1-C2-N3 -0.5 0.0 0.5
C1-C6 1.430 1.429 -0.001 C6-C1-C2-H12 179.8 180.0 0.2
C1-H11 1.085 1.090 0.005 H11-C1-C2-N3 179.8 -180.0 0.2
C2-N3 1.363 1.353 -0.010 H11-C1-C2-H12 0.1 0.0 -0.1
C2-H12 1.086 1.097 0.012 C2-C1-C6-C5 0.5 0.0 -0.5
N3-C4 1.389 1.378 -0.010 C2-C1-C6-O7 -179.8 -180.0 -0.2
N3-C9 1.462 1.469 0.007 H11-C1-C6-C5 -179.7 180.0 -0.3
C4-C5 1.374 1.382 0.008 H11-C1-C6-O7 0.0 0.0 0.0
C4-C10 1.498 1.505 0.007 C1-C2-N3-C4 0.5 0.0 -0.5
C5-C6 1.454 1.463 0.010 C1-C2-N3-C9 178.6 -180.0 1.4
C5-O8 1.356 1.359 0.003 H12-C2-N3-C4 -179.8 180.0 -0.2
C6-O7 1.260 1.235 -0.025 H12-C2-N3-C9 -1.7 0.0 1.7
O8-H13 0.994 0.972 -0.022 C2-N3-C4-C5 -0.7 0.0 0.7
C9-H14 1.090 1.113 0.023 C2-N3-C4-C10 -179.8 180.0 -0.2
C9-H15 1.092 1.114 0.022 C9-N3-C4-C5 -178.7 -180.0 -1.3
C9-H16 1.093 1.114 0.021 C9-N3-C4-C10 2.2 0.0 -2.2
C10-H17 1.095 1.112 0.016 C2-N3-C9-H14 5.5 0.0 -5.5
C10-H18 1.091 1.111 0.020 C2-N3-C9-H15 124.7 119.9 -4.8
C10-H19 1.095 1.112 0.017 C2-N3-C9-H16 -114.0 -119.9 -5.9
Angles(o) C4-N3-C9-H14 -176.4 180.0 -3.6
C2-C1-C6 120.5 121.3 0.8 C4-N3-C9-H15 -57.2 -60.1 -2.9
C2-C1-H11 119.8 123.7 3.9 C4-N3-C9-H16 64.1 60.1 -4.0
C6-C1-H11 119.6 114.9 -4.7 N3-C4-C5-C6 0.8 0.0 -0.8
C1-C2-N3 122.7 122.8 0.2 N3-C4-C5-O8 -179.6 180.0 -0.4
C1-C2-H12 121.8 121.8 -0.1 C10-C4-C5-C6 179.9 -180.0 0.1
N3-C2-H12 115.5 115.4 -0.1 C10-C4-C5-O8 -0.5 0.0 0.5
C2-N3-C4 120.7 119.0 -1.7 N3-C4-C10-H17 63.8 60.3 -3.5
C2-N3-C9 119.5 119.1 -0.5 N3-C4-C10-H18 -177.2 180.0 -2.8
C4-N3-C9 119.7 121.9 2.2 N3-C4-C10-H19 -58.0 -60.3 -2.3
N3-C4-C5 117.9 121.5 3.5 C5-C4-C10-H17 -115.3 -119.7 -4.4
N3-C4-C10 119.8 119.1 -0.7 C5-C4-C10-H18 3.7 0.0 -3.7
C5-C4-C10 122.3 119.4 -2.8 C5-C4-C10-H19 122.9 119.7 -3.2
C4-C5-C6 123.9 120.8 -3.1 C4-C5-C6-C1 -0.7 0.0 0.7
C4-C5-O8 121.6 124.2 2.6 C4-C5-C6-O7 179.6 -180.0 0.4
C6-C5-O8 114.5 115.0 0.5 O8-C5-C6-C1 179.7 -180.0 0.3
C1-C6-C5 114.3 114.6 0.3 O8-C5-C6-O7 0.0 0.0 0.0
C1-C6-O7 127.7 121.6 -6.1 C4-C5-O8-H13 -179.5 180.0 -0.5
C5-C6-O7 118.0 123.9 5.8 C6-C5-O8-H13 0.1 0.0 -0.1
C5-O8-H13 101.4 101.5 0.1 Improper dihedrals(o)   
N3-C9-H14 108.4 112.5 4.1 C6-C1-C5-O7 -0.2 0.0 0.2
N3-C9-H15 110.5 111.1 0.5    
N3-C9-H16 110.8 111.1 0.2    
H14-C9-H15 108.8 107.0 -1.8    
H14-C9-H16 108.9 107.0 -1.9    
H15-C9-H16 109.2 108.0 -1.3    
C4-C10-H17 112.1 110.8 -1.3    
C4-C10-H18 108.1 112.6 4.5    
C4-C10-H19 112.1 110.8 -1.3    
H17-C10-H18 108.1 106.9 -1.2    
H17-C10-H19 108.1 108.6 0.5    
H18-C10-H19 108.2 106.9 -1.3    
The coordinates highlighted in blue are specific for CP20 and were optimised in this study. 
 




Figure 6-2 Interaction orientations of CP20 with water molecules that were used for charge optimisationa.  
a Only a single water molecule is interacting with CP20 during each calculation; all water molecules are shown 
simultaneously only for convenience. The CP25-water and CP94-water models were set up by analogy with this CP20-
water model.   
 
Table 6-2 Interaction energies (kcal mol-1) and distances (Å) of CP20-water complexes in different 
geometries. 
interaction geometry ∆E(HF)a ∆E(MM) ∆∆E r(HF)b r(MM) ∆r 
O4⋯HOH -7.34 -7.27 0.07 1.99 1.74 -0.25 
O3⋯HOH -2.18 -2.20 -0.02 2.23 2.04 -0.19 
H5⋯OHH -2.00 -2.04 -0.04 2.53 2.39 -0.14 
H6⋯OHH -5.46 -5.52 -0.06 2.35 2.30 -0.05 
|M|   0.05   0.16 
a HF/6-31G(d) interaction energies are scaled by a factor 1.16 (Vanommeslaeghe et al., 2010); b HF interaction 
distances are not scaled; however, bulk phase hydrogen bonds should be roughly 0.2 shorter than vacuum  
(Vanommeslaeghe et al., 2010). |M|: mean of absolute deviations. 
 
Table 6-3 Dipole moment (Debye) of CP20 calculated at HF/6-31G(d)a, MP2/6-31G(d) and MM. 
μ HF/6-31G(d) MP2/6-31G(d) MM 
X -6.5759 -7.3776 -5.7950
Y -1.0023 -1.3748 -2.2027
Z -0.0104 -0.0137 -0.0001
total 6.6519 7.5046 6.1995
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Table 6-4 CP20 vibrational spectra calculated at scaled MP2/6-31G(d) and MM. 
MP2/6-31G(d)a MM ∆Frequency%b
46.5 41.4 -11.0% 
109.9 118.6 7.9% 
119.3 131.1 9.9% 
174.0 164.4 -5.5% 
241.7 287.3 18.9% 
302.6 313.3 3.5% 
304.0 343.4 13.0% 
322.5 362.0 12.2% 
348.4 366.6 5.2% 
431.6 439.8 1.9% 
446.5 464.5 4.0% 
474.2 474.1 0.0% 
477.4 528.1 10.6% 
559.6 558.9 -0.1% 
567.7 606.0 6.7% 
651.2 647.1 -0.6% 
660.2 661.1 0.1% 
737.3 716.2 -2.9% 
741.6 757.0 2.1% 
811.4 820.6 1.1% 
874.9 928.3 6.1% 
1002.9 965.5 -3.7% 
1020.7 1002.4 -1.8% 
1037.4 1003.9 -3.2% 
1100.8 1010.7 -8.2% 
1103.1 1065.4 -3.4% 
1147.1 1115.7 -2.7% 
1218.3 1200.2 -1.5% 
1254.8 1263.4 0.7% 
1281.7 1300.3 1.5% 
1358.9 1363.5 0.3% 
1382.9 1403.7 1.5% 
1387.2 1407.4 1.5% 
1429.4 1413.7 -1.1% 
1448.7 1427.8 -1.4% 
1456.0 1437.1 -1.3% 
1464.4 1479.1 1.0% 
1472.7 1498.3 1.7% 
1497.6 1543.6 3.1% 
1543.8 1576.1 2.1% 
1615.0 1633.0 1.1% 
1629.6 1768.2 8.5% 
2924.8 2904.9 -0.7% 
2943.1 2907.8 -1.2% 
2993.7 2957.2 -1.2% 
3025.8 2957.7 -2.3% 
3042.8 2958.9 -2.8% 
3052.5 2959.4 -3.0% 
3065.8 2997.5 -2.2% 
3084.9 3001.6 -2.7% 
3241.9 3675.5 13.4% 
 |M| 4.0% 
a scaled by a factor of 0.943 (Vanommeslaeghe et al., 2010); b ∆Frequency% = (MM_frequency - MP2/6-
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Figure 6-3 Potential energy surfaces of CP20 calculated at MP2/6-31G(d) (blue) and MM (red) for the 
optimised dihedrals and improper dihedrals. 
Y-axis is only shown up to 8 kcal mol-1 because this is the only important region for MD simulations at 300 K. 
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Figure 6-3 continued 
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Table 6-5 Atom types and charges specific for CP20. 
Atom Atom type Charge (initial) 
Charge 
(final) 
C1 CG2R62 -0.050  -0.480  
C2 CG2R62 0.179  -0.310  
N3 NG2R61 -0.811  0.065  
C4 CG2R62 0.177  0.195  
C5 CG2R62 0.161  0.040  
C6 CG2R63 0.604  0.635  
O7 OG2D4 -0.477  -0.645  
O8 OG311 -0.529  -0.550  
C9 CG331 -0.267  -0.230  
C10 CG331 -0.165  -0.310  
H11 HGR62 0.077  0.270  
H12 HGR62 0.141  0.340  
H13 HGP1 0.420  0.440  
H14 HGA3 0.090  0.090  
H15 HGA3 0.090  0.090  
H16 HGA3 0.090  0.090  
H17 HGA3 0.090  0.090  
H18 HGA3 0.090  0.090  
H19 HGA3 0.090  0.090  
 
 






















Bonds     
CG2R62 OG311   334.30 1.411 150.00  1.2900 
Angles     
CG2R62 CG2R62 OG311  45.20 120.00 30.00  119.82 
CG2R63 CG2R62 OG311  45.20 120.00 30.00  108.68 
CG331 CG2R62 NG2R61  45.80 122.30 20.00  135.00 
CG2R62 CG2R63 CG2R62  40.00 118.00 30.00  90.26 
CG2R62 OG311 HGP1  65.00 108.00 50.00  102.41 
Dihedrals     
CG2R63 CG2R62 CG2R62 CG331 3.10 2 180.00 1.50  2 180.00 
CG331 CG2R62 CG2R62 OG311 2.40 2 180.00 4.50  2 180.00 
NG2R61 CG2R62 CG2R62 OG311 1.00 2 180.00 8.30  2 180.00 
CG2R62 CG2R62 CG2R63 CG2R62 6.00 2 180.00 1.80  2 180.00 
OG311 CG2R62 CG2R63 CG2R62 3.10 2 180.00 1.80  2 180.00 
OG311 CG2R62 CG2R63 OG2D4 1.00 2 180.00 2.00  2 180.00 
HGR62 CG2R62 CG2R63 CG2R62 1.00 2 180.00 0.00  1 0.00 
NG2R61 CG2R62 CG331 HGA3 0.00 6 180.00 0.65  3 0.00 
CG331 CG2R62 NG2R61 CG2R62 4.00 2 180.00 3.50  2 180.00 
CG331 CG2R62 NG2R61 CG331 11.00 2 180.00 0.00  1 180.00 
HGR62 CG2R62 NG2R61 CG2R62 4.60 2 180.00 5.00  2 180.00 
CG2R62 CG2R62 OG311 HGP1 0.99 2 180.00 2.00  2 180.00 
CG2R63 CG2R62 OG311 HGP1 0.99 2 180.00 2.00  2 180.00 
Improper 
dihedrals     
CG2R63 CG2R62 CG2R62 OG2D4 90.00 0 0.00 15.00  0 0.00 
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Table 6-7 CHARMM molecular mechanics (MM) equilibrium geometry of CP25, compared to QM MP2/6-
31G(d) level. 
Coordinate MP2 MM Difference Coordinate MP2 MM Difference
Bond lengths(Å)    Dihedrals(o)    
C1-C2 1.372  1.365 -0.006 H3-C1-C2-H4 0.0  -0.9  -0.9 
C1-H3 1.085  1.088 0.003 H3-C1-C2-N11 -178.9  -179.1  -0.3 
C1-C18 1.430  1.436 0.006 C18-C1-C2-H4 -179.4  178.2  -2.3 
C2-H4 1.087  1.094 0.008 C18-C1-C2-N11 1.7  0.0  -1.6 
C2-N11 1.364  1.353 -0.011 C2-C1-C18-C15 -1.8  0.9  2.8 
C5-H6 1.095  1.114 0.019 C2-C1-C18-O19 179.4  -179.3  1.3 
C5-H7 1.092  1.110 0.018 H3-C1-C18-C15 178.7  -179.9  1.4 
C5-C9 1.526  1.537 0.011 H3-C1-C18-O19 0.0  -0.1  -0.1 
C5-N11 1.468  1.466 -0.002 C1-C2-N11-C5 -172.9  -172.1  0.8 
H8-C12 1.096  1.111 0.016 C1-C2-N11-C14 -1.6  -2.8  -1.2 
C9-C20 1.527  1.536 0.009 H4-C2-N11-C5 8.1  9.7  1.5 
C9-H24 1.097  1.114 0.017 H4-C2-N11-C14 179.5  178.9  -0.5 
C9-H25 1.096  1.113 0.017 H6-C5-C9-C20 -61.2  -60.5  0.8 
H10-C12 1.091  1.111 0.020 H6-C5-C9-H24 60.6  60.8  0.1 
N11-C14 1.389  1.374 -0.015 H6-C5-C9-H25 176.6  178.2  1.5 
C12-H13 1.094  1.110 0.016 H7-C5-C9-C20 57.3  57.4  0.1 
C12-C14 1.499  1.501 0.002 H7-C5-C9-H24 179.1  178.7  -0.5 
C14-C15 1.375  1.376 0.001 H7-C5-C9-H25 -64.9  -63.9  0.9 
C15-O17 1.357  1.359 0.002 N11-C5-C9-C20 179.2  -179.4  1.4 
C15-C18 1.454  1.460 0.007 N11-C5-C9-H24 -58.9  -58.2  0.8 
H16-O17 0.994  0.970 -0.023 N11-C5-C9-H25 57.1  59.2  2.2 
C18-O19 1.260  1.236 -0.025 H6-C5-N11-C2 -35.4  -35.4  0.1 
C20-C21 1.527  1.536 0.009 H6-C5-N11-C14 153.3  155.6  2.3 
C20-H26 1.099  1.114 0.015 H7-C5-N11-C2 -150.7  -149.8  0.9 
C20-H27 1.099  1.113 0.015 H7-C5-N11-C14 38.0  41.1  3.1 
C21-C22 1.527  1.535 0.008 C9-C5-N11-C2 86.0  85.4  -0.6 
C21-H28 1.098  1.113 0.015 C9-C5-N11-C14 -85.3  -83.7  1.6 
C21-H29 1.098  1.113 0.015 C5-C9-C20-C21 179.3  180.0  0.6 
C22-C23 1.526  1.530 0.004 C5-C9-C20-H26 -58.8  -58.8  0.0 
C22-H30 1.097  1.114 0.017 C5-C9-C20-H27 57.5  58.7  1.2 
C22-H31 1.097  1.114 0.017 H24-C9-C20-C21 58.3  58.5  0.2 
C23-H32 1.094  1.111 0.018 H24-C9-C20-H26 -179.9  179.7  -0.5 
C23-H33 1.094  1.111 0.017 H24-C9-C20-H27 -63.6  -62.8  0.8 
C23-H34 1.094  1.111 0.017 H25-C9-C20-C21 -58.9  -58.1  0.7 
Angles(o)  H25-C9-C20-H26 63.0  63.1  0.1 
C2-C1-H3 119.9  121.3 1.3 H25-C9-C20-H27 179.3  -179.4  1.3 
C2-C1-C18 120.4  121.4 1.1 C2-N11-C14-C12 178.2  179.2  1.0 
H3-C1-C18 119.7  117.3 -2.4 C2-N11-C14-C15 1.7  4.4  2.7 
C1-C2-H4 122.0  120.9 -1.1 C5-N11-C14-C12 -10.7  -12.2  -1.5 
C1-C2-N11 122.9  121.9 -0.9 C5-N11-C14-C15 172.8  173.0  0.2 
H4-C2-N11 115.2  117.2 2.0 H8-C12-C14-N11 -64.2  -62.4  1.9 
H6-C5-H7 107.0  106.4 -0.6 H8-C12-C14-C15 112.1  112.4  0.3 
H6-C5-C9 110.4  109.9 -0.5 H10-C12-C14-N11 177.1  178.2  1.1 
H6-C5-N11 107.1  106.7 -0.4 H10-C12-C14-C15 -6.5  -7.1  -0.5 
H7-C5-C9 111.1  111.8 0.8 H13-C12-C14-N11 57.8  58.6  0.8 
H7-C5-N11 108.6  108.9 0.3 H13-C12-C14-C15 -125.9  -126.6  -0.8 
C9-C5-N11 112.4  112.8 0.4 N11-C14-C15-O17 178.7  178.1  -0.5 
C5-C9-C20 112.0  112.7 0.7 N11-C14-C15-C18 -2.1  -3.4  -1.3 
C5-C9-C21 108.7  109.3 0.7 C12-C14-C15-O17 2.2  3.4  1.2 
C5-C9-C22 109.3  109.7 0.4 C12-C14-C15-C18 -178.5  -178.1  0.4 
C20-C9-C21 110.1  108.9 -1.2 C14-C15-O17-H16 179.0  179.2  0.2 
C20-C9-C22 110.0  108.8 -1.2 C18-C15-O17-H16 -0.3  0.7  0.9 
C21-C9-C22 106.6  107.3 0.7 C14-C15-C18-C1 2.1  0.8  -1.4 
C2-N11-C5 118.1  115.9 -2.2 C14-C15-C18-O19 -179.0  -179.0  0.0 
C2-N11-C14 120.6  120.7 0.1 O17-C15-C18-C1 -178.6  179.4  -2.1 
C5-N11-C14 120.7  122.5 1.7 O17-C15-C18-O19 0.3  -0.4  -0.7 
H8-C12-H10 108.0  107.2 -0.8 C9-C20-C21-C22 179.9  179.9  0.0 
H8-C12-H13 108.2  108.8 0.6 C9-C20-C21-H28 -58.1  -58.8  -0.7 
H8-C12-C14 111.8  110.5 -1.3 C9-C20-C21-H29 57.9  58.7  0.8 
H10-C12-H13 108.2  106.9 -1.3 H26-C20-C21-C22 58.0  58.7  0.7 
H10-C12-C14 107.9  112.0 4.1 H26-C20-C21-H28 180.0  180.0  0.0 
H13-C12-C14 112.5  111.2 -1.3 H26-C20-C21-H29 -64.0  -62.6  1.5 
N11-C14-C12 120.3  119.2 -1.1 H27-C20-C21-C22 -58.1  -58.7  -0.7 
N11-C14-C15 117.8  119.8 2.0 H27-C20-C21-H28 63.9  62.6  -1.4 
C12-C14-C15 121.8  120.7 -1.0 H27-C20-C21-H29 179.9  -180.0  0.1 
C14-C15-O17 121.6  124.0 2.3 C20-C21-C22-C23 -180.0  180.0  0.0 
C14-C15-C18 124.0  121.8 -2.2 C20-C21-C22-H30 -57.9  -58.4  -0.5 
O17-C15-C18 114.4  114.2 -0.2 C20-C21-C22-H31 57.9  58.4  0.5 
C15-O17-H16 101.4  101.3 -0.1 H28-C21-C22-C23 58.0  58.4  0.4 
C1-C18-C15 114.3  114.2 -0.1 H28-C21-C22-H30 -179.9  180.0  -0.1 
C1-C18-O19 127.6  122.0 -5.6 H28-C21-C22-H31 -64.1  -63.2  0.9 
C15-C18-O19 118.1  123.8 5.7 H29-C21-C22-C23 -58.0  -58.4  -0.4 
C9-C20-C21 112.7  112.6 -0.1 H29-C21-C22-H30 64.1  63.1  -0.9 
C9-C20-H26 109.5  109.1 -0.4 H29-C21-C22-H31 179.9  180.0  0.0 
C9-C20-H27 109.5  109.2 -0.4 C21-C22-C23-H32 180.0  180.0  0.0 
C21-C20-H26 109.3  109.0 -0.2 C21-C22-C23-H33 -59.8  -60.0  -0.1 
C21-C20-H27 109.3  109.1 -0.2 C21-C22-C23-H34 59.8  60.0  0.1 
H26-C20-H27 106.4  107.8 1.4 H30-C22-C23-H32 58.2  58.6  0.4 
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C20-C21-C22 113.1  113.1 -0.1 H30-C22-C23-H33 178.4  178.7  0.3 
C20-C21-H28 109.3  109.3 0.0 H30-C22-C23-H34 -61.9  -61.4  0.5 
C20-C21-H29 109.3  109.3 0.0 H31-C22-C23-H32 -58.2  -58.6  -0.4 
C22-C21-H28 109.3  108.8 -0.5 H31-C22-C23-H33 61.9  61.4  -0.5 
C22-C21-H29 109.3  108.7 -0.6 H31-C22-C23-H34 -178.4  -178.6  -0.3 
H28-C21-H29 106.3  107.5 1.2 Improper dihedrals(o)    
C21-C22-C23 112.7  113.1 0.4 C18-C1-C15-O19 0.6 -0.1 -0.7
C21-C22-H30 109.2  108.9 -0.3     
C21-C22-H31 109.2  108.9 -0.3     
C23-C22-H30 109.6  109.2 -0.4     
C23-C22-H31 109.6  109.2 -0.4     
H30-C22-H31 106.4  107.4 1.1     
C22-C23-H32 111.4  110.6 -0.8     
C22-C23-H33 110.9  110.5 -0.3     
C22-C23-H34 110.9  110.5 -0.3     
H32-C23-H33 107.9  108.4 0.5     
H32-C23-H34 107.9  108.4 0.5     
H33-C23-H34 107.8  108.3 0.5     
The coordinates highlighted in blue are specific for CP25 and were optimised in this study. 
 
 
Table 6-8 Interaction energies (kcal mol-1) and distances (Å) of CP25-water complexes in different 
geometries. 
interaction geometry ∆E(HF)a ∆E(MM) ∆∆E r(HF)b r(MM) ∆r 
O4⋯HOH -6.31 -6.26 0.05 1.99 1.77  -0.22  
O3⋯HOH -2.05 -2.03 0.02 2.25 2.07  -0.18  
H5⋯OHH -0.81 -0.81 0.00 2.54 2.49  -0.05  
H6⋯OHH -3.85 -3.82 0.03 2.36 2.37  0.01  
|M|   0.03   0.12 
a HF/6-31G(d) interaction energies are scaled by a factor 1.16 (Vanommeslaeghe et al., 2010); b HF interaction 
distances are not scaled; however, bulk phase hydrogen bonds should be roughly 0.2 shorter than vacuum  
(Vanommeslaeghe et al., 2010). |M|: mean of absolute deviations. 
 
Table 6-9 Dipole moment (Debye) of CP25 calculated at HF/6-31G(d)a, MP2/6-31G(d) and MM. 
μ HF/6-31G(d) MP2/6-31G(d) MM 
X 6.5160 7.1907 6.5488 
Y -0.0025 -0.0752 0.0872 
Z 2.6133 2.7548 2.9091 
total 7.0205 7.7007 7.1664 
a The HF dipole moment is calculated on the MP2/6-31G(d) optimised geometry. 
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Table 6-10 CP25 vibrational spectra calculated at scaled MP2/6-31G(d) and MM. 
MP2/6-31G(d)a MM ∆Frequency%b
29.3 31.7 8.2% 
32.2 33.3 3.4% 
44.9 56.4 25.6% 
83.3 82.7 -0.7% 
95.4 89.3 -6.4% 
119.6 112.0 -6.4% 
129.9 133.7 2.9% 
149.8 149.1 -0.5% 
165.3 156.8 -5.1% 
178.8 171.7 -4.0% 
229.8 234.5 2.0% 
245.0 245.3 0.1% 
265.9 280.0 5.3% 
303.4 313.0 3.2% 
306.8 330.0 7.6% 
327.6 348.4 6.3% 
359.1 386.9 7.7% 
410.8 397.6 -3.2% 
414.5 432.4 4.3% 
447.0 446.7 -0.1% 
471.5 461.3 -2.2% 
486.8 491.4 0.9% 
531.6 519.8 -2.2% 
564.6 561.6 -0.5% 
574.0 606.1 5.6% 
657.8 631.7 -4.0% 
660.9 654.0 -1.0% 
703.9 723.8 2.8% 
720.8 742.0 2.9% 
744.2 747.9 0.5% 
754.1 759.1 0.7% 
777.5 788.5 1.4% 
814.9 818.6 0.5% 
869.4 859.0 -1.2% 
875.4 916.0 4.6% 
881.7 925.6 5.0% 
972.5 937.2 -3.6% 
993.8 971.8 -2.2% 
1013.3 1008.0 -0.5% 
1015.4 1009.1 -0.6% 
1022.9 1017.3 -0.5% 
1037.5 1028.0 -0.9% 
1042.5 1030.3 -1.2% 
1054.7 1047.6 -0.7% 
1108.7 1052.1 -5.1% 
1128.3 1069.2 -5.2% 
1148.9 1102.3 -4.1% 
1196.0 1111.6 -7.1% 
1208.1 1137.7 -5.8% 
1214.9 1144.0 -5.8% 
1238.2 1161.8 -6.2% 
1247.9 1171.9 -6.1% 
1271.9 1194.2 -6.1% 
1275.7 1222.2 -4.2% 
1285.7 1231.3 -4.2% 
1292.4 1258.0 -2.7% 
1297.5 1261.4 -2.8% 
1330.9 1299.6 -2.4% 
1358.6 1344.3 -1.1% 
1368.7 1351.3 -1.3% 
1373.0 1359.3 -1.0% 
1384.9 1405.4 1.5% 
1387.3 1413.9 1.9% 
1388.9 1421.8 2.4% 
1454.1 1422.7 -2.2% 
1459.0 1426.0 -2.3% 
1461.4 1426.4 -2.4% 
1465.4 1428.0 -2.6% 
1469.9 1429.1 -2.8% 
1471.9 1434.8 -2.5% 
1475.9 1443.6 -2.2% 
1478.1 1476.2 -0.1% 
1484.7 1513.4 1.9% 
1487.5 1538.2 3.4% 
1540.9 1568.5 1.8% 
1610.1 1624.6 0.9% 
1627.5 1768.5 8.7% 
2901.6 2853.8 -1.6% 
2907.3 2887.5 -0.7% 
2918.3 2893.4 -0.9% 
2924.1 2896.5 -0.9% 
2926.1 2901.8 -0.8% 
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2926.7 2905.0 -0.7% 
2941.0 2907.2 -1.1% 
2950.7 2911.4 -1.3% 
2953.1 2921.5 -1.1% 
2969.3 2926.9 -1.4% 
2978.9 2934.1 -1.5% 
2995.4 2940.3 -1.8% 
3010.0 2957.5 -1.7% 
3012.2 2958.9 -1.8% 
3014.4 2959.5 -1.8% 
3040.3 2960.3 -2.6% 
3057.0 2995.0 -2.0% 
3082.8 2997.9 -2.8% 
3240.5 3677.8 13.5% 
 |M| 3.1% 
a scaled by a factor of 0.943 (Vanommeslaeghe et al., 2010); b ∆Frequency% = (MM_frequency - MP2/6-
31G(d)_frequency) (MP2/6-31G(d)_frequency)-1 x100%; |M|: mean of absolute ∆Frequency%. 
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Figure 6-4 Potential energy surfaces of CP25 calculated at MP2/6-31G(d) (blue) and MM (red) for the 
optimised dihedrals and improper dihedrals. 
Y-axis is only shown up to 8 kcal mol-1 because this is the only important region for MD simulations at 300 K. 
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Figure 6-4 continued 
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Figure 6-4 continued 
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Table 6-11 Atom types and charges specific for CP25. 
Atom Atom type Charge (initial) 
Charge 
(final) 
C1 CG2R62 -0.050  -0.406  
C2 CG2R62 0.176  -0.129  
H3 HGR62 0.077  0.190  
H4 HGR62 0.141  0.221  
C5 CG321 -0.106  -0.054  
H6 HGA2 0.090  0.090  
H7 HGA2 0.090  0.090  
H8 HGA3 0.090  0.090  
C9 CG321 -0.180  -0.137  
H10 HGA3 0.090  0.090  
N11 NG2R61 -0.861  -0.164  
C12 CG331 -0.165  -0.280  
H13 HGA3 0.090  0.090  
C14 CG2R62 0.174  0.262  
C15 CG2R62 0.161  -0.034  
H16 HGP1 0.420  0.412  
O17 OG311 -0.529  -0.489  
C18 CG2R63 0.604  0.493  
O19 OG2D4 -0.477  -0.540  
C20 CG321 -0.195  -0.196  
C21 CG321 -0.178  -0.165  
C22 CG321 -0.183  -0.063  
C23 CG331 -0.269  -0.361  
H24 HGA2 0.090  0.090  
H25 HGA2 0.090  0.090  
H26 HGA2 0.090  0.090  
H27 HGA2 0.090  0.090  
H28 HGA2 0.090  0.090  
H29 HGA2 0.090  0.090  
H30 HGA2 0.090  0.090  
H31 HGA2 0.090  0.090  
H32 HGA3 0.090  0.090  
H33 HGA3 0.090  0.090  
H34 HGA3 0.090  0.090  
 























Bonds          
CG2R62 OG311   334.30  1.411 150.00   1.300 
CG321 NG2R61   400.00  1.456 300.00   1.440 
Angles          
CG2R62 CG2R62 OG311  45.20  120.00 30.00   111.30 
CG2R63 CG2R62 OG311  45.20  120.00 30.00   100.39 
CG331 CG2R62 NG2R61  45.80  122.30 20.00   119.60 
CG2R62 CG2R63 CG2R62  40.00  118.00 30.00   89.30 
CG321 CG321 NG2R61  70.00  113.50 20.00   107.80 
NG2R61 CG321 HGA2  51.50  109.50 40.00   103.50 
CG2R62 NG2R61 CG321  70.00  120.50 50.00   108.00 
CG2R62 OG311 HGP1  65.00  108.00 50.00   102.50 
Dihedrals          
CG2R63 CG2R62 CG2R62 CG331 3.10 2 180.00 1.80  2 180.00 
CG331 CG2R62 CG2R62 OG311 2.40 2 180.00 5.00  2 180.00 
NG2R61 CG2R62 CG2R62 OG311 1.00 2 180.00 9.00  2 180.00 
CG2R62 CG2R62 CG2R63 CG2R62 6.00 2 180.00 2.60  2 180.00 
OG311 CG2R62 CG2R63 CG2R62 3.10 2 180.00 1.80  2 180.00 
OG311 CG2R62 CG2R63 OG2D4 1.00 2 180.00 2.00  2 180.00 
HGR62 CG2R62 CG2R63 CG2R62 1.00 2 180.00 0.01  1 0.00 
NG2R61 CG2R62 CG331 HGA3 0.00 6 180.00 0.58  3 12.00 
CG2R62 CG2R62 NG2R61 CG321 11.00 2 180.00 3.60  2 190.00 
CG331 CG2R62 NG2R61 CG2R62 4.00 2 180.00 4.60  2 180.00 
CG331 CG2R62 NG2R61 CG321 11.00 2 180.00 3.00  1 170.00 
HGR62 CG2R62 NG2R61 CG2R62 4.60 2 180.00 4.60  2 180.00 
HGR62 CG2R62 NG2R61 CG321 0.30 2 180.00 6.00  1 190.00 
CG2R62 CG2R62 OG311 HGP1 0.99 2 180.00 2.00  2 180.00 
CG2R63 CG2R62 OG311 HGP1 0.99 2 180.00 2.00  2 180.00 
CG321 CG321 CG321 NG2R61 0.20 3 0.00 0.20  3 0.00 
NG2R61 CG321 CG321 HGA2 0.20 3 0.00 0.00  3 0.00 
CG321 CG321 NG2R61 CG2R62 1.80 1 0.00 0.50  2 0.00 
HGA2 CG321 NG2R61 CG2R62 0.00 3 0.00 0.00  4 0.00 
Improper 
dihedrals          
CG2R63 CG2R62 CG2R62 OG2D4 90.00 0 0.00 15.00  0 0.00 
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Table 6-13 CHARMM molecular mechanics (MM) equilibrium geometry of CP94, compared to QM MP2/6-
31G(d) level. 
Coordinate QM MM Difference Coordinate QM MM Difference
Bond lengths(Å)    Dihedrals(o)    
C1-C2 1.372  1.362 -0.010 H3-C1-C2-H4 0.1  0.0  -0.1 
C1-H3 1.085  1.089 0.004 H3-C1-C2-N11 -178.9  -179.4  -0.5 
C1-C18 1.431  1.434 0.004 C18-C1-C2-H4 -179.6  -179.7  -0.2 
C2-H4 1.086  1.091 0.004 C18-C1-C2-N11 1.5  0.9  -0.6 
C2-N11 1.364  1.358 -0.006 C2-C1-C18-C15 -1.9  0.2  2.1 
C5-H6 1.091  1.110 0.019 C2-C1-C18-O19 179.6  -180.0  0.5 
C5-H7 1.093  1.114 0.020 H3-C1-C18-C15 178.5  -179.5  2.0 
C5-C9 1.523  1.533 0.010 H3-C1-C18-O19 0.0  0.3  0.4 
C5-N11 1.469  1.471 0.002 C1-C2-N11-C5 -172.8  -171.5  1.4 
H8-C12 1.094  1.109 0.015 C1-C2-N11-C14 -2.0  -2.3  -0.2 
C9-H20 1.093  1.112 0.019 H4-C2-N11-C5 8.2  9.2  1.0 
C9-H21 1.092  1.111 0.019 H4-C2-N11-C14 179.0  178.3  -0.6 
C9-H22 1.094  1.111 0.016 H6-C5-C9-H20 178.1  178.3  0.2 
H10-C12 1.094  1.112 0.019 H6-C5-C9-H21 -62.0  -61.8  0.1 
N11-C14 1.390  1.381 -0.009 H6-C5-C9-H22 58.3  58.3  0.0 
C12-C13 1.533  1.535 0.002 H7-C5-C9-H20 59.2  59.6  0.4 
C12-C14 1.501  1.500 -0.001 H7-C5-C9-H21 179.2  179.5  0.3 
C13-H23 1.094  1.110 0.016 H7-C5-C9-H22 -60.6  -60.4  0.2 
C13-H24 1.093  1.112 0.020 N11-C5-C9-H20 -59.8  -59.8  0.1 
C13-H25 1.094  1.111 0.016 N11-C5-C9-H21 60.1  60.1  0.0 
C14-C15 1.375  1.381 0.006 N11-C5-C9-H22 -179.6  -179.7  -0.1 
C15-O17 1.357  1.356 -0.001 H6-C5-N11-C2 -147.9  -149.3  -1.4 
C15-C18 1.452  1.458 0.006 H6-C5-N11-C14 41.4  41.9  0.5 
H16-O17 0.994  0.967 -0.027 H7-C5-N11-C2 -33.0  -34.8  -1.8 
C18-O19 1.260  1.237 -0.023 H7-C5-N11-C14 156.3  156.4  0.1 
Angles(o)  C9-C5-N11-C2 88.3  86.6  -1.8 
C2-C1-H3 119.9  119.7 -0.2 C9-C5-N11-C14 -82.4  -82.2  0.2 
C2-C1-C18 120.4  120.7 0.2 C2-N11-C14-C12 176.3  177.5  1.2 
H3-C1-C18 119.7  119.6 -0.1 C2-N11-C14-C15 3.0  2.5  -0.5 
C1-C2-H4 121.8  119.8 -2.0 C5-N11-C14-C12 -13.2  -14.1  -0.9 
C1-C2-N11 123.0  123.4 0.4 C5-N11-C14-C15 173.5  170.9  -2.6 
H4-C2-N11 115.2  116.8 1.6 H8-C12-C13-H23 -64.3  -62.5  1.8 
H6-C5-H7 106.9  106.8 -0.1 H8-C12-C13-H24 176.0  177.5  1.5 
H6-C5-C9 111.6  111.8 0.2 H8-C12-C13-H25 56.4  58.0  1.6 
H6-C5-N11 108.6  107.9 -0.7 H10-C12-C13-H23 178.8  -180.0  1.3 
H7-C5-C9 110.6  110.3 -0.4 H10-C12-C13-H24 59.0  60.0  1.0 
H7-C5-N11 106.7  106.8 0.1 H10-C12-C13-H25 -60.6  -59.5  1.1 
C9-C5-N11 112.1  112.9 0.8 C14-C12-C13-H23 60.9  60.1  -0.7 
C5-C9-H20 110.2  110.6 0.3 C14-C12-C13-H24 -58.8  -59.9  -1.0 
C5-C9-H21 111.0  110.8 -0.2 C14-C12-C13-H25 -178.5  -179.4  -0.9 
C5-C9-H22 110.2  110.5 0.3 H8-C12-C14-N11 40.2  37.6  -2.6 
H20-C9-H21 108.2  108.1 -0.1 H8-C12-C14-C15 -146.7  -147.4  -0.7 
H20-C9-H22 108.5  108.3 -0.2 H10-C12-C14-N11 156.0  153.7  -2.3 
H21-C9-H22 108.5  108.4 -0.1 H10-C12-C14-C15 -30.9  -31.3  -0.4 
C2-N11-C5 117.9  116.2 -1.7 C13-C12-C14-N11 -84.6  -85.6  -1.0 
C2-N11-C14 120.4  119.8 -0.6 C13-C12-C14-C15 88.5  89.4  0.9 
C5-N11-C14 121.0  123.0 2.0 N11-C14-C15-O17 177.4  178.1  0.7 
H8-C12-H10 106.5  106.2 -0.4 N11-C14-C15-C18 -3.7  -1.5  2.2 
H8-C12-C13 110.7  111.3 0.6 N12-C14-C15-O17 4.0  3.0  -1.1 
H8-C12-C14 111.4  110.4 -1.0 N12-C14-C15-C18 -177.0  -176.6  0.5 
H10-C12-C13 109.2  110.1 1.0 C14-C15-O17-H16 178.0  -179.7  2.4 
H10-C12-C14 106.5  108.8 2.3 C18-C15-O17-H16 -1.1  -0.1  1.0 
C13-C12-C14 112.2  109.9 -2.3 C14-C15-C18-C1 3.1  0.1  -3.0 
C12-C13-H23 111.6  111.1 -0.5 C14-C15-C18-O19 -178.2  -179.7  -1.5 
C12-C13-H24 109.6  110.2 0.6 C17-C15-C18-C1 -177.9  -179.4  -1.5 
C12-C13-H25 110.8  110.4 -0.4 C17-C15-C18-O19 0.8  0.7  -0.1 
H23-C13-H24 108.1  108.2 0.2 Improper dihedrals(o)    
H23-C13-H25 108.2  108.6 0.3 C18-C1-C15-O19    
H24-C13-H25 108.4  108.2 -0.2     
N11-C14-C12 121.3  121.4 0.1     
N11-C14-C15 117.7  119.2 1.5     
C12-C14-C15 120.6  119.2 -1.4     
C14-C15-O17 121.1  122.8 1.7     
C14-C15-C18 124.3  122.8 -1.5     
O17-C15-C18 114.6  114.4 -0.2     
C15-O17-H16 101.4  101.5 0.1     
C1-C18-C15 114.0  114.1 0.1     
C1-C18-O19 127.8  122.5 -5.3     
C15-C18-O19 118.2  123.4 5.2     
The coordinates highlighted in blue are specific for CP94 and were optimised in this study. 
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Table 6-14 Interaction energies (kcal mol-1) and distances (Å) of CP94-water complexes in different 
geometries. 
interaction geometry ∆E(HF)a ∆E(MM) ∆∆E r(HF)b r(MM) ∆r 
O4⋯HOH -5.02 -5.09 -0.07 1.99 1.81  -0.18  
O3⋯HOH -0.89 -0.83 0.06 2.23 2.22  -0.01  
H5⋯OHH 0.44 0.53 0.09 2.53 2.86  0.33  
H6⋯OHH -2.76 -2.69 0.07 2.35 2.44  0.09  
|M|   0.07   0.15 
a HF/6-31G(d) interaction energies are scaled by a factor 1.16 (Vanommeslaeghe et al., 2010); b HF interaction 
distances are not scaled; however, bulk phase hydrogen bonds should be roughly 0.2 shorter than vacuum  
(Vanommeslaeghe et al., 2010). |M|: mean of absolute deviations. 
 
Table 6-15 Dipole moment (Debye) of CP94 calculated at HF/6-31G(d)a, MP2/6-31G(d) and MM. 
μ HF/6-31G(d) MP2/6-31G(d) MM 
X -6.4330 -7.1254 -6.1167 
Y -1.1340 -1.3571 0.5134 
Z -0.7036 -0.8248 -0.1523 
total 6.5700 7.3002 6.1401 
a The HF dipole moment is calculated on the MP2/6-31G(d) optimised geometry. 
Table 6-16 CP94 vibrational spectra calculated at scaled MP2/6-31G(d) and MM. 
MP2/6-31G(d)a MM ∆Frequency%b
57.8 65.9 14.0% 
76.8 88.5 15.2% 
95.6 108.3 13.3% 
113.1 113.2 0.1% 
160.8 161.7 0.6% 
206.6 209.3 1.3% 
211.2 217.8 3.1% 
236.8 224.9 -5.0% 
307.6 291.8 -5.1% 
330.7 306.3 -7.4% 
335.0 318.0 -5.1% 
364.2 341.0 -6.4% 
385.2 381.7 -0.9% 
455.5 412.4 -9.5% 
473.5 467.3 -1.3% 
516.0 472.0 -8.5% 
542.1 503.3 -7.2% 
568.8 516.7 -9.2% 
577.2 591.3 2.4% 
644.7 639.5 -0.8% 
665.7 667.0 0.2% 
719.0 711.0 -1.1% 
744.9 723.6 -2.9% 
759.6 785.1 3.4% 
776.6 839.4 8.1% 
815.4 857.9 5.2% 
874.4 883.4 1.0% 
931.7 962.1 3.3% 
962.0 972.8 1.1% 
1018.2 984.2 -3.3% 
1055.0 1026.3 -2.7% 
1069.5 1028.2 -3.9% 
1078.9 1035.5 -4.0% 
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1122.2 1040.4 -7.3% 
1146.1 1068.6 -6.8% 
1206.1 1136.9 -5.7% 
1229.3 1139.0 -7.3% 
1247.4 1160.6 -7.0% 
1268.3 1195.2 -5.8% 
1282.4 1276.5 -0.5% 
1328.1 1322.0 -0.5% 
1339.8 1331.9 -0.6% 
1367.5 1399.8 2.4% 
1379.4 1416.3 2.7% 
1384.9 1421.0 2.6% 
1391.1 1423.3 2.3% 
1455.2 1423.8 -2.2% 
1462.5 1425.7 -2.5% 
1468.3 1431.0 -2.5% 
1472.3 1431.9 -2.7% 
1475.8 1473.8 -0.1% 
1481.6 1503.0 1.4% 
1488.5 1525.0 2.5% 
1540.0 1555.9 1.0% 
1604.0 1617.4 0.8% 
1627.7 1755.9 7.9% 
2928.4 2853.0 -2.6% 
2935.9 2855.0 -2.8% 
2948.7 2886.5 -2.1% 
2964.6 2890.1 -2.5% 
2994.9 2903.4 -3.1% 
3010.9 2903.7 -3.6% 
3017.9 2958.3 -2.0% 
3024.2 2958.5 -2.2% 
3026.4 2960.3 -2.2% 
3037.4 2960.5 -2.5% 
3057.2 2992.1 -2.1% 
3082.2 2997.9 -2.7% 
3241.3 3678.4 13.5% 
 |M| 4.0% 
a scaled by a factor of 0.943 (Vanommeslaeghe et al., 2010); b ∆Frequency% = (MM_frequency - MP2/6-
31G(d)_frequency) (MP2/6-31G(d)_frequency)-1 x100%; |M|: mean of absolute ∆Frequency%. 
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Figure 6-5 Potential energy surfaces of CP94 calculated at MP2/6-31G(d) (blue) and MM (red) for the 
optimised dihedrals and improper dihedrals. 
Y-axis is only shown up to 8 kcal mol-1 because this is the only important region for MD simulations at 300 K. 
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Figure 6-5 continued 
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Figure 6-5 continued 
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Table 6-17 Atom types and charges specific for CP94. 
Atom Atom type Charge (initial) 
Charge 
(final) 
C1 CG2R62 -0.050  -0.272  
C2 CG2R62 0.176  -0.084  
H3 HGR62 0.077  0.072  
H4 HGR62 0.141  0.145  
C5 CG321 -0.109  0.020  
H6 HGA2 0.090  0.090  
H7 HGA2 0.090  0.090  
H8 HGA2 0.090  0.090  
C9 CG331 -0.269  -0.269  
H10 HGA2 0.090  0.090  
N11 NG2R61 -0.898  -0.052  
C12 CG321 -0.172  -0.048  
C13 CG331 -0.267  -0.283  
C14 CG2R62 0.301  -0.035  
C15 CG2R62 0.148  -0.092  
H16 HGP1 0.420  0.402  
O17 OG311 -0.529  -0.349  
C18 CG2R63 0.608  0.388  
O19 OG2D4 -0.477  -0.443  
H20 HGA3 0.090  0.090  
H21 HGA3 0.090  0.090  
H22 HGA3 0.090  0.090  
H23 HGA3 0.090  0.090  
H24 HGA3 0.090  0.090  
H25 HGA3 0.090  0.090  
 























Bonds          
CG2R62 CG321   230.00  1.490 150.00   1.45 
CG2R62 OG311   334.30  1.411 110.00   1.31 
CG321 NG2R61   400.00  1.456 300.00   1.45 
Angles          
CG2R62 CG2R62 CG321  40.00  124.20 10.00   150.90 
CG2R62 CG2R62 OG311  45.20  120.00 20.00   104.80 
CG2R63 CG2R62 OG311  45.20  120.00 20.00   99.00 
CG321 CG2R62 NG2R61  45.80  122.30 10.00   135.00 
CG2R62 CG2R63 CG2R62  40.00  118.00 20.00   83.00 
CG2R62 CG321 CG331  51.80  107.50 10.00   100.50 
CG2R62 CG321 HGA2  49.30  107.50 30.00   105.50 
CG331 CG321 NG2R61  70.00  120.00 20.00   108.50 
NG2R61 CG321 HGA2  51.50  109.50 40.00   104.00 
CG2R62 NG2R61 CG321  70.00  120.50 50.00   114.00 
CG2R62 OG311 HGP1  65.00  108.00 60.00   103.10 
Dihedrals          
CG2R63 CG2R62 CG2R62 CG321 3.10 2 180.00 2.00  2 180.00 
CG321 CG2R62 CG2R62 OG311 2.40 2 180.00 5.00  2 180.00 
NG2R61 CG2R62 CG2R62 OG311 1.00 2 180.00 9.00  2 180.00 
CG2R62 CG2R62 CG2R63 CG2R62 6.00 2 180.00 2.80  2 185.00 
OG311 CG2R62 CG2R63 CG2R62 3.10 2 180.00 1.80  2 180.00 
OG311 CG2R62 CG2R63 OG2D4 1.00 2 180.00 2.00  2 180.00 
HGR62 CG2R62 CG2R63 CG2R62 1.00 2 180.00 0.01  1 0.00 
CG2R62 CG2R62 CG321 CG331 0.23 2 180.00 0.75  2 0.00 
CG2R62 CG2R62 CG321 HGA2 0.00 6 0.00 0.00  4 0.00 
NG2R61 CG2R62 CG321 CG331 0.23 2 180.00 0.75  2 0.00 
NG2R61 CG2R62 CG321 HGA2 0.00 6 0.00 0.00  4 0.00 
CG2R62 CG2R62 NG2R61 CG321 11.00 2 180.00 2.80  2 180.00 
CG321 CG2R62 NG2R61 CG2R62 4.00 2 180.00 4.60  2 180.00 
CG321 CG2R62 NG2R61 CG321 11.00 2 180.00 2.80  1 110.00 
HGR62 CG2R62 NG2R61 CG2R62 4.60 2 180.00 5.00  2 180.00 
HGR62 CG2R62 NG2R61 CG321 0.30 2 180.00 2.80  1 180.00 
CG2R62 CG2R62 OG311 HGP1 0.99 2 180.00 2.30  2 180.00 
CG2R63 CG2R62 OG311 HGP1 0.99 2 180.00 2.30  2 180.00 
CG2R62 CG321 CG331 HGA3 0.04 3 0.00 0.12  3 0.00 
NG2R61 CG321 CG331 HGA3 0.20 3 0.00 0.17  3 0.00 
CG331 CG321 NG2R61 CG2R62 1.80 1 0.00 0.50  2 0.00 
HGA2 CG321 NG2R61 CG2R62 0.00 3 0.00 0.00  4 0.00 
Improper 
dihedrals          
CG2R63 CG2R62 CG2R62 OG2D4 90.00 0 0.00 10.00  0 0.00 
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6.3.2 Hydration study using LAMMPS 
The MD simulations of the hydrated HPOs were carried out for three successive 1 ns periods 
and the corresponding O3-O (H2O) and O4-O (H2O) RDF results are presented in Figures 6-6 
(CP20, O3), 6-7 (CP20, O4), 6-8 (CP25, O3), 6-9 (CP25, O4), 6-10 (CP94, O3) and 6-11 (CP94, 
O4). There are no significant differences for each 1 ns simulation and thus, the final RDF results 
were averaged over the full 3 ns period and they are presented in Figures 6-12 (O3) and 6-13 
(O4). In general, CP20 was found to have the strongest hydrogen bonding interaction with H2O, 
followed by CP25 and CP94 (the weakest) and HPO O4 was found to have stronger hydrogen 
bonding interaction with H2O than HPO O3 with respect to the height and position of RDF, g(r), 
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Figure 6-6 O3–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated CP20 
during three successive 1 ns periodsa. 
a 1st ns (black line), 2nd ns (red line), 3rd ns (blue line). 
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Figure 6-7 O4–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated CP20 
during three successive 1 ns periodsa. 
a 1st ns (black line), 2nd ns (red line), 3rd ns (blue line). 
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Figure 6-8 O3–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated CP25 
during three successive 1 ns periodsa. 
a 1st ns (black line), 2nd ns (red line), 3rd ns (blue line). 
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Figure 6-9 O4–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated CP25 
during three successive 1 ns periodsa. 
a 1st ns (black line), 2nd ns (red line), 3rd ns (blue line). 
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Figure 6-10 O3–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated CP94 
during three successive 1 ns periodsa. 
a 1st ns (black line), 2nd ns (red line), 3rd ns (blue line). 
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Figure 6-11 O4–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated CP94 
during three successive 1 ns periodsa. 
a 1st ns (black line), 2nd ns (red line), 3rd ns (blue line). 
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Figure 6-12 O3–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated 
HPOsa during the whole 3 ns period. 
a CP20 (black line), CP25 (red line), CP94 (blue line). 









































Figure 6-13 O4–O (H2O) radial distribution function (a) and coordination number (b) for the hydrated 
HPOsa during the whole 3 ns period. 
a CP20 (black line), CP25 (red line), CP94 (blue line). 
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6.4 Discussion 
Novel CHARMM force fields specific for the three HPOs were developed and shown to 
reproduce QM geometries, water interactions, vibrational spectra and PESs. The calculated MM 
dipole moments, however, are close to (not higher than) QM values probably because slightly 
different MM geometries were obtained. If the HPOs are surrounded by explicit H2O molecules 
shielding the potential hydrogen bonding between O3-H and O4, the angle differences will be 
reduced. Although some of MM PESs have higher energy barriers (by greater than 1 kcal mol-1) 
than QM ones, the positions of the maxima and minima are close, indicating that the MM 
geometries will be close to QM ones but with the corresponding MM dihedrals more rotationally 
constrained.  
The optimisation of atom charges in CHARMM requires structures interacting with water 
molecules to reproduce their water interaction energies and distances from QM calculations. 
This methodology is superior to the fixed atom charges only determined from QM-computed 
electrostatic potentials in vacuum, if developed force fields are applied in MD simulations with 
explicit water molecules. 
Comparison of the initially assigned parameters from the CHARMM website with the final 
optimised parameters (Tables 6-5, 6-6 for CP20, 6-11, 6-12 for CP25 and 6-17, 6-18 for CP94) 
demonstrates that the corresponding atom charges and the force constants of bonds, angles, 
dihedrals and improper dihedrals are significantly different from one another. The greatest 
difference in partial charge is seen for the 1-nitrogen atom on the HPO ring. The different partial 
charges indicate that there are no structures which are similar enough to HPOs within the 
current CHARMM force field database. HPOs possess the unique 3,4-oxygen atoms forming 
resonance structures with the 1-nitrogen atom and this makes the compounds significantly 
different from the catechols and pyridins in the CHARMM database. Because the unique 
resonance occurs within the HPO ring, the electron density at the 1-nitrogen atom is much less 
negative than the value predicted by the CHARMM website. 
Comparison of the optimised parameters for the three different HPOs demonstrates that 
the atom charges are significantly different from each other, but for the same types of bonds, 
angles, dihedrals and improper dihedrals, the force constants are closely similar. This indicates 
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that methyl or alkyl groups can influence the electron density significantly within the structure 
but have a lesser effect on the compound’s geometry. 
The order of hydrogen bonding strength with H2O for the three HPOs justified by RDFs 
follows the same order of HPO-water interaction energies (Tables 6-2, 6-8 and 6-14). The RDFs 
computed from the three successive 1 ns periods are not significantly different from each other, 
indicating that a 1 ns simulation is sufficient to model the HPO-water system. In an attempt to 
improve the statistics, all 3 ns simulations were averaged together to provide the final RDFs. 
The H2O coordination number with an origin at O3 for CP94 is found to be significantly lower 
than those calculated for the other two HPOs (Figure 6-12). This can be explained by CP94 
possessing a 2-ethyl rather than the 2-methyl substituent present in the other two HPOs, the 
larger alkyl chain repelling significantly more H2O molecules. 
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Chapter 7 Summary and Conclusions 
The purpose of this project was to predict the physicochemical properties of 3-hydroxypyridin-4-
one (HPO) Fe3+-chelating agents using novel computational methods. The hydroxyl pKa values 
of the HPOs were predicted using quantum mechanical (QM) static calculations with an 
experimentally fitted model to obtain results in excellent agreement with experimental data (with 
the mean of the absolute deviations from measured values (|M|) being ~0.20, compared to the 
estimated experimental errors of ~0.10). The QM static computation assists with the assignment 
of different pKa values for the two oxygen atoms of HPOs (associated with experimental metal 
affinity determination), and this is particularly useful when the HPOs possess more than two pKa 
values. The hydroxyl pKa values of three alkyl HPOs were further predicted using QM molecular 
dynamic (MD) simulations to provide reasonable predictions (|M| = 0.34) and additional insights 
into the atomistic details of the whole deprotonation process, and hydration configurations and 
dynamics. It was found that the distribution of substituted methyl groups around the HPO 
aromatic ring would appear to affect the surrounding water networking significantly and this 
impacts upon their pKa values. The hydroxyl pKa values were also predicted using existing 
QSPR commercial software and thermodynamic cycle calculations but yielded results of 
insufficient accuracy. In general, choice of pKa prediction methods should depend on the 
purpose and the quantity of existing experimental data. For example, if more than a hundred 
compounds, with known pKa values for a sufficient number of analogues, need screening for 
drug discovery, the QSPR methods are relatively cost effective. However, if compounds contain 
functional groups that possess hydrogen bonding donors and/or acceptors, or that exhibit strong 
electronic effect, the higher level computational methods are required. In the future, if the power 
of computers is improved significantly, QM-based methods can take much less computing time, 
thereby competing for the screening of a large number of compounds with high accuracy. 
The (Fe3+) log K1 values of the HPOs were predicted in excellent agreement with 
experimental data (|M| ~0.32, compared to the estimated experimental errors of ~0.15) using 
the analogous methodology as the QM static calculations with a regression model for the 
hydroxyl pKa prediction. Prior to the construction of the prediction model, an expected linear 
relationship between the pKas and (Fe3+) log K1 was utilised to verify the experimental (Fe3+) log 
K1 values. From this, ten previously reported HPOs with substituents carrying hydrogen bonding 
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donors/acceptors were found to possess incorrect (Fe3+) log K1 values and then were re-
characterised using a 10 : 1 molar ratio of ligand : Fe3+. To date, the QM method for predicting 
the metal affinity of chelators in absolute value has been only reported in the work detailed here. 
The methodology can in principle be applied to predict HPO (Fe3+) log β2 and log β3 and this will 
require more computing power and time. In addition, special attention is required for the 
prediction of HPO (Fe3+) log β3 because the extra stabilising effect from solvent (entropy 
contributions) plays a significant role for the [Fe3+(HPO)3] complexes or the corresponding 
hexadentate chelators. Thus, QM MD with explicit solvent molecules is suggested to investigate 
their hydration configurations and this requires extensive computing power. 
With a view to the prediction of HPO membrane permeability, novel CHARMM force 
fields specific for three HPOs were parameterised and tested with explicit water molecules using 
classical MD simulations. Because of a limited research time, the actual membrane permeability 
values were not predicted. In the future, this can be carried out using constraints on the depth of 
HPO insertion in explicitly hydrated biological membranes through classical MD simulations, in 
which the constraint forces can be converted to free energies, and thus to membrane 
permeability values although extensive computing power is required. 
 In conclusion, there are many possibilities for carrying out a diversity of research with 
the increasing power of computers. Computational chemistry is a great tool for researchers to 
understand the molecular details of natural phenomena, which are often difficult to obtain 
through physical experiments. From this, humans can understand the world in depth and 
improve their quality of life. 
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Appendix A UV/Vis spectra and speciation plots 
A.1 CP28 
 
Figure A - 1 UV/Vis spectra and corresponding speciation plots for CP28. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 1476.9 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 492.1 μM 















































































Figure A - 2 UV/Vis spectra and corresponding speciation plots for CP38. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 682.9 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 462.3 μM 



















































































 Figure A - 3 UV/Vis spectra and corresponding speciation plots for CP40. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 316.7 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 471.3 μM 




















































































Figure A - 4 UV/Vis spectra and corresponding speciation plots for CP70. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 316.7 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 471.3 μM 

























































































Figure A - 5 UV/Vis spectra and corresponding speciation plots for CP102. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 366.4 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 462.0 μM 




















































































Figure A - 6 UV/Vis spectra and corresponding speciation plots for CP110. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 492.2 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 462.0 μM 






















































































Figure A - 7 UV/Vis spectra and corresponding speciation plots for CP111. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 29.0 μM over the pH range 2-11; 
(c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 582.5 μM and 



















































































Figure A - 8 UV/Vis spectra and corresponding speciation plots for CP352. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 349.2 μM over the pH range 2-
10; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 455.0 μM 



















































































Figure A - 9 UV/Vis spectra and corresponding speciation plots for CP359. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 789.8 μM over the pH range 2-
10; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 458.5 μM 



















































































Figure A - 10 UV/Vis spectra and corresponding speciation plots for CP364. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 830.4 μM over the pH range 2-
10; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 466.0 μM 




















































































Figure A - 11 UV/Vis spectra and corresponding speciation plots for CP365. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 762.0 μM over the pH range 2-
10; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 458.6 μM 




















































































Figure A - 12 UV/Vis spectra and corresponding speciation plots for CP366. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 33.1 μM over the pH range 2-10; 
(c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 639.0 μM and 



















































































Figure A - 13 UV/Vis spectra and corresponding speciation plots for CP370. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 805.0 μM over the pH range 2-
10; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 468.8 μM 





















































































Figure A - 14 UV/Vis spectra and corresponding speciation plots for CP372. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 778.4 μM over the pH range 2-
10; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 464.4 μM 



















































































Figure A - 15 UV/Vis spectra and corresponding speciation plots for CP374. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 634.8 μM over the pH range 2-
10; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 470.6 μM 


















































































Figure A - 16 UV/Vis spectra and corresponding speciation plots for CP375. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 568.6 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 462.3 μM 


















































































Figure A - 17 UV/Vis spectra and corresponding speciation plots for CP414. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 137.6 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 538.9 μM 

























































































Figure A - 18 UV/Vis spectra and corresponding speciation plots for CP510. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 1002.6 μM over the pH range 1-
9; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 454.0 μM 





















































































Figure A - 19 UV/Vis spectra and corresponding speciation plots for CP529. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 746.6 μM over the pH range 1-8; 
(c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 430.7 μM and 




















































































Figure A - 20 UV/Vis spectra and corresponding speciation plots for CP545. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 724.3 μM over the pH range 1-7; 
(c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 429.9 μM and 























































































Figure A - 21 UV/Vis spectra and corresponding speciation plots for CP616. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 1392.0 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 461.3 μM 






















































































Figure A - 22 UV/Vis spectra and corresponding speciation plots for CP751. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 714.4 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 462.5 μM 


















































































Figure A - 23 UV/Vis spectra and corresponding speciation plots for YMF1. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 831.3 μM over the pH range 2-
10; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 444.5 μM 
























































































Figure A - 24 UV/Vis spectra and corresponding speciation plots for YMF3. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 1278.7 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 460.1 μM 




















































































Figure A - 25 UV/Vis spectra and corresponding speciation plots for YMF4. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 2877.5 μM over the pH range 4-
12; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 461.1 μM 





















































































Figure A - 26 UV/Vis spectra and corresponding speciation plots for YMF6. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 1538.1 μM over the pH range 
0.5-12; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 582.5 



















































































Figure A - 27 UV/Vis spectra and corresponding speciation plots for YMF13. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 1478.6 μM over the pH range 
0.5-12; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 458.3 




















































































Figure A - 28 UV/Vis spectra and corresponding speciation plots for YMMO1. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 959.4 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 407.2 μM 



















































































Figure A - 29 UV/Vis spectra and corresponding speciation plots for CN116. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 729.4 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 468.2 μM 



















































































Figure A - 30 UV/Vis spectra and corresponding speciation plots for CN128. 
(a)(b): the UV/Vis spectra and corresponding speciation plots for pure ligand when [L] = 728.3 μM over the pH range 2-
11; (c)(d): the UV/Vis spectra and corresponding speciation plots for ligand in the presence of Fe3+ when [L] = 467.2 μM 
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